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Tobacco use increases the odds of suffering and dying prematurely from a host of chronic 
disease, including heart disease, stroke, cancer, lung diseases, and mental illness. There is limited 
published data especially from Canada on the prevalence, etiology, consumption patterns and 
treatment of tobacco use among persons with mental illness. 
Objectives: 
First, understand the social epidemiology and describe the characteristics of a typical smoker 
with mental illness. Second, understand the likelihood of receiving smoking cessation 
interventions in mental health institutions of Ontario. 
Methods:   
Secondary analysis of the data obtained using the Ontario Mental Health Reporting System 
(OMHRS). Census level data collected from all the individuals admitted to mental health 
institutions in Ontario during the period of October 2005 and September 2006. Cross tabs were 
used to analyze the social epidemiology of smokers. Odds ratios were calculated for the 
likelihood of the psychiatric diagnosis and receiving smoking cessation intervention. 
Results:  
Forty-seven percent of the individuals admitted in mental health beds during the study duration 
were smokers. The mean age of smokers was lower as compared to non-smokers. Individuals 
with the diagnosis of substance use disorder were the most likely to be smokers as compared to 
the reference group. Smokers scoring higher on CAGE score or having a diagnosis of substance 
use disorder and had more than 5 drinks of alcohol in the last 14 days are more likely to receive 
the intervention as compared to other smokers. 
Conclusion:  
The results of this study suggest that significantly huge populations of individuals in mental 
health institutions are smokers. The smoking prevalence is higher in males and these males are 
also more likely to have a diagnosis of substance-related disorder. There is a lack of smoking 
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Tobacco use increases the odds of suffering and dying prematurely from a host of chronic 
diseases, including heart disease, stroke, cancer, lung diseases, and mental illness (US 
Department of Health and Human Services, 2004).  The costs associated with tobacco use are 
borne by individuals, families, employers, and entire communities. Tobacco-related death and 
illness deprives families of breadwinners and nations of a healthy workforce by killing people at 
the height of their productivity. In a report released by the Canadian Centre on Substance Abuse, 
loss of productivity accounts for the largest share of the total costs related to tobacco (over 73%), 
followed by direct health care costs (almost 26%) in Ontario (Rehm et al., 2006). 
Although the prevalence of cigarette smoking has dropped in Canada and developed 
nations more generally, rates remain unacceptably high. Results from representative national 
surveys indicate that, between 1985 and 2006, smoking prevalence rates in Canada have fallen 
from 35% to 19% (Health Canada, 2006). Despite this, over 5 million Canadians continue to 
smoke, and tobacco use remains the primary cause of preventable death among Canadians 
(Canadian Tobacco Use Monitoring Survey, 2006). For nations such as Canada, the United 
States, and the UK, who have set a goal to reduce disparities in health status, it is a particular 
concern that the prevalence of tobacco use varies widely across various overlapping 
subpopulations, including aboriginals, those with mental illness, young and middle-aged adults, 
as well as those with low socio-economic status. 
Tobacco use among persons with mental illness is of particular concern for at least two 
reasons. First, compared with other populations, very little is known about the prevalence, 
etiology, consumption patterns, and treatment of tobacco use among persons with mental illness. 
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The little we do know suggests that tobacco use among this group may be a significant problem. 
For example, available data suggests that up to 60% of individuals with psychiatric disorders are 
smokers (Leonard et al., 2001); prevalence rates range from 30-50% in patients with mood 
disorders and exceed 70% in patients with schizophrenia and substance-related disorder 
(Hennigfield, Clayton, and Pollin 1990; Hughes, Hatsukami, Mitchell, and Dahlgren 1986; 
Patkar et al. 2002). Second, per capita consumption may be greater among persons with mental 
illness. Although less than twenty percent of Canadians will personally experience a mental 
illness during their lifetime (Health Canada, 2002), estimates suggest that in countries like the 
United States and Canada, 44% of the cigarettes smoked are consumed by individuals with a 
psychiatric or substance abuse disorder (Lasser et al., 2000). Other studies have reported that this 
population is two to three times more likely to be tobacco dependent than the general population 
(Lohr & Flynn, 1992; WHO, 2001). Collectively, these data suggest that tobacco use is a 
significant problem in persons with mental illness. Understanding more about tobacco use and 
tobacco cessation in this group would be highly beneficial since it has the potential to improve 
the health of these individuals. It will also increase the knowledge about the broader tobacco 
epidemic. 
The thesis is organized by first providing a brief review of what is currently known about 
tobacco usage and its relation to psychiatric diagnosis, etiology, patterns of consumption, etc. 
Based on the review of the literature, research questions are then outlined. Following the 
research questions, the methods used to answer the research questions will be explained. Results 
will follow, and finally the discussion section will summarize the findings, importance of the 
findings, and future directions.  
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The purpose of this thesis is to use an available data source of individuals hospitalized for 
mental illness to learn more about the use of tobacco. More specifically, this thesis seeks to 
understand the social epidemiology of institutionalized smokers by looking at the relationship 
with respect to basic demographic factors such as age, sex, race, marital status, level of 
education, sources of income, etc. It is also designed to further understand the factors which 
make a person more likely to receive smoking cessation programs being offered in mental health 
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While the prevalence and consumption rates for tobacco use among persons with mental 
illness are higher than those in the general population, there are variations in consumption 
patterns among those with psychiatric illnesses. A more detailed understanding of these 
variations may shed light on the etiology of tobacco use for persons with mental illness and/or 
how to more effectively assist them to stop smoking.   
One potentially important variation in prevalence rates appears to be related to the type of 
psychiatric diagnosis. For example, a recent paper summarizing the recent literature on the use of 
tobacco among individuals with mental illness or an addiction reported that the rate of cigarette 
smoking is highest among individuals with psychotic and substance-use disorders (Williams and 
Ziedonis, 2004). The types of psychotic disorders most closely linked with tobacco use included 
schizophrenia, schizoaffective disorder, schizophreniform disorder and brief psychotic disorder. 
They also reported that the rate remains high for depression, anxiety, and personality disorders as 
well.  
There are over 4,000 components in tobacco. Among the various components, nicotine 
acts directly by binding to the specific receptors in the body. These receptors, when stimulated, 
alter the levels of neurotransmitters and produce different effects depending on the area where 
the receptors are located. The specific location of the nicotinic receptors in the brain had been the 
topic of discussion. It is difficult to generalize the specific locations from animal brain to human 
brain. According to more limited studies done on human brain tissue, nicotinic receptors appear 
to be widely distributed in the central nervous system, with high concentrations in the thalamus, 
striatum, hippocampal formation, cerebral cortex, basal ganglia and cerebellum (Breeze, Adams, 
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Logel, Drebing, Rollins & Barnhart, 1997). Positron-emission tomography using radioactive 
nicotine as the tracer ligand confirms the widespread distribution of these receptors (Nordberg, 
1995).  
It is thought that several neurotransmitters are involved in the pathogenesis of psychiatric 
and substance-related disorders (Kalman et al., 2005). For example, it is known that patients with 
the diagnosis of depression have low levels of serotonin and nor-epinephrine. The imbalance of 
these neurotransmitters, whether resulting from or due to mental illness alone or in combination 
with cigarette smoking, suggests that the prevalence and consumption of cigarette smoking may 
be different according to the particular psychiatric diagnosis. 
2.1  Tobacco and psychiatric diagnosis 
The prevalence of smoking differs with the psychiatric diagnosis of the individual. The 
literature review suggests individuals with the diagnosis of schizophrenia and mood disorders 
(including depression, bipolar disorders, mania, etc.) represent a major proportion of the smoker 
population with mental illness. Among individuals diagnosed with schizophrenia, higher rates of 
smoking were found in various clinical as well as population-based samples (Kalman et al., 
2005).  
In a study by Diwan and colleagues (1998), a very high current smoking rate (up to 86%) 
was reported among individuals with the diagnosis of schizophrenia. The rate was three to four 
times higher than the general population. However, the low statistical power of the data and the 
study participants coming from a circumscribed population (male veterans) were the major 
limitations of the study. The study was conducted in an outpatient clinic using a smoking 
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questionnaire administered to 99 patients with primary non-substance-use Axis I diagnoses.  
Using a variety of methodological techniques, the smoking rate was found to be 50% 
among individuals with mood disorders (Glassman, 1998; Glass et al., 1992; Adlaf, Paglia & 
Ivis, 1999; Poirier et al., 2002). In individuals with alcohol and substance-related disorders, rates 
of smoking range from 70 to 90% (Battjes, 1998; Berger & Schweigler, 1972; Glassman et al., 
1990; Williams et al., 2005). Another study found that the initiation rate of daily smoking among 
individuals diagnosed with schizophrenia was higher as compared to the individuals with the 
diagnosis of mood disorders or controls after the age of 20 years (De Leon, 2002). In contrast to 
persons with schizoaffective, depressive and/or substance-related disorders, persons with other 
psychiatric diagnoses smoke at rates equal to or lower than those seen in general non-psychiatric 
populations (Poirier et al., 2002; Tanskanen et al., 1997). It should be noted that the sample sizes 
in these studies were relatively small, but even so, the high rates of cigarette smoking in this 
group compared to the general non-psychiatric population, is a definite cause for concern. 
The high prevalence of cigarette smoking among persons with only certain types of 
mental illness potentially sheds light on the etiology of tobacco use and how to treat it more 
effectively. Some of the researchers have postulated that individuals with schizophrenia may 
smoke cigarettes to improve their psychiatric symptoms, cognitive functions and/ or alleviate the 
effects of medications. This is reinforced by a review of the literature which suggests that 
individuals with schizophrenia who smoke have lower rates of neuroleptic-induced Parkinsonism 
(Decina et al., 1990; Menza et al., 1991). Much research has shown that cigarette smoking has 
been also used to reduce depressive symptoms (Glassman et al., 1990; Khantzian, 1997). Animal 
models of depression suggest that nicotine (one of the main ingredients of tobacco smoke) can 
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have long-term antidepressant-like properties and nicotinic receptors are mediating these effects 
(Quattrocki, Baird and Yurgelum-Todd, 2000). While review of the literature suggests that 
smoking is used to reduce depressive symptoms, it also has been hypothesized or shown to 
increase the likelihood of suffering from depression (Quattrocki, Baird, and Yurgelum-Todd, 
2000). Irrespective of the mechanism/ action, the co-occurrence of smoking and depression has 
been found in other studies as well. 
The correlation of smoking and depression, and the discovery of antidepressant-like 
properties of nicotine have led to the use of antidepressant medications to treat nicotine 
dependence. For example, antidepressant medication Bupropion is being used as an approved 
first line therapy to treat nicotine dependence. 
The use of antipsychotic medications in different psychiatric diagnoses is also affected by 
the smoking status of those individuals. Research has shown that the pharmacology of 
antipsychotic differs in smokers compared to non-smokers. This is probably due to the fact that 
cigarette smoke contains monoamine oxidase (MAO) inhibitors which degrade catecholamine 
neurotransmitters, e.g., serotonin, dopamine, epinephrine and nor-epinephrine. Many of the 
antipsychotic exert their effect by altering the level of these neurotransmitters; therefore, the 
MAO inhibitors from cigarette smoke affect the level of these neurotransmitters. As a result of 
these alterations, the pharmacology of antipsychotic change with respect to the smoking habits of 
the individuals. For example, it was found that ad libitum smoking increases after initiation of 
haloperidol, relative to baseline rates when patients are free of antipsychotic medications 
(McEvoy et al., 1995a; McEvoy et al., 1995b). There is also evidence to support that those 
individuals who were treated with clozapine, risperidone or olanzapine (all atypical 
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antipsychotic), smoked fewer cigarettes when treated with conventional antipsychotic 
medications. 
This review of literature clearly shows that the prevalence of smoking is very high especially in 
individuals with the diagnoses of schizophrenia and mood disorders. It also found that rates vary 
within the diagnosis as well. To better understand these differences and the smoking pattern, 
further research is needed to fill the knowledge gaps in this area. 
2.2  Severity of illness and its relationship to cigarette smoking   
Severity of mental illness is thought to be directly related with cigarette smoking. A study 
conducted in Ireland found a relationship between mood disorders, smoking, and heavy smoking 
with history of psychotic symptoms (Corvin et al., 2001). The study found that smoking is 
associated with increased severity of psychotic symptoms in the study population. 
In a population-based prevalence study, persons with multiple lifetime psychiatric 
diagnoses were found to have higher rates of smoking, and they smoked more heavily than 
persons with only one DSM-III-R diagnosis (Lasser, 2000). Multiple lifetime psychiatric 
diagnoses were used as a measure of the severity of psychiatric illness. However, it is difficult to 
conclude whether smoking was the reason for the multiple psychiatric admissions or whether 
multiple psychiatric admissions led to the higher smoking rates, but certainly the association of 
these two conditions is a cause of concern.  
On the other hand, Dixon et al. (2007) reported no relationship between smoking severity and the 
Brief Psychiatry Rating Scale (BPRS). Study participants included a relatively large group of 
individuals with the diagnosis of schizophrenia. It is possible that further inclusion of other 
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individuals with a wide range of psychiatric diagnosis may show different results. More data is 
needed to understand the association in various diagnostic groups. 
2.3  Various forms of tobacco usage   
Tobacco can be consumed in various forms, such as smokeless tobacco, cigarettes, cigars, 
pipes etc. Studies have shown that the pulmonary absorption is more efficient than oral or nasal 
absorption (the mechanism used in other forms of tobacco). This is due to the fact that nicotine is 
immediately absorbed and transported to the brain by way of the carotid artery within 7 – 10 
seconds due to the large surface area of the lungs.  
Canadian Tobacco Usage Monitoring Survey (CTUMS) data show that the prevalence of 
recent use (i.e., use in the last 30 days) of smokeless tobacco (i.e., chewed or oral snuff) was 
0.6% among those aged 15 or older in 2005. A review of the literature did not find any 
significant data on the pattern of tobacco usage in individuals with mental illness compared to 
the general population. Therefore, based on the available research and the recent trend of tobacco 
usage, it is difficult to conclude whether or not individuals with mental illness use the same 
forms of tobacco in comparison to general population. However, for the purpose of this thesis, 
the term tobacco usage and cigarette smoking will be used synonymously. 
2.4  The relationship between smoking initiation and mental illness 
There is limited evidence to address causality between smoking initiation and mental 
illness. However, research has shown that the age of onset for both of these conditions are very 
close to each other. In a pilot study, it was found that 50% of patients had started daily smoking 
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before the onset of the first schizophrenic psychosis (de Leon, 1996). The study found that the 
mean difference between the initiation of regular smoking and the onset of psychiatric disorder 
was significantly lower than that among subjects with other psychoses or those with non-
psychotic disorders. Another study found a close relationship between the age of initiation of 
regular smoking and age of onset of mental disorder (Riala et al., 2005). The study found a mean 
difference between the initiation of regular smoking and the onset of psychiatric disorder among 
patients with schizophrenia was 2.3 (SD 6.6) years, which was statistically significantly lower 
than that among subjects with other psychoses or those with non-psychotic disorders. The mean 
difference among patients with schizophrenia also remained lower when compared with specific 
diagnostic groups, namely, non-psychotic mood disorders and substance use disorder. On the 
other hand, the same study found that the mean age of initiation of regular smoking among 
patients with schizophrenia did not differ statistically significantly from that of the control group.   
Recent studies have shown that the age of onset of psychiatric illnesses among smokers 
and non-smokers is not statistically different (Kelly and McCreadie, 1999; Beratis et al., 2002). 
However, there is some evidence to suggest the association between early onset of mental illness 
and smoking status of the individual. For example, individuals having a history of cigarette 
smoking and later being diagnosed with schizophrenia, presented with an earlier onset of 
symptoms as compared to those without a smoking history (Sandyk and Kay, 1991; Goff et al., 
1992). 
In other studies, initiation of smoking occurred before the onset of symptoms in 
approximately 86% - 90% of the patients (Beratis et al., 2001; Kelly and McCreadie, 1999). It 
was also found in the same study that the mean age of smoking onset preceded the onset of 
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schizophrenia by 11 years.  
The review of literature also found evidence suggesting that smoking initiation may lead 
to developing depression. For example, it was found that smoking does not appear directly to 
cause depression but the likelihood of suffering from depression is correlated with nicotine 
dependence and the number of cigarettes consumed. Kendler and colleagues also concluded that 
smoking does not induce depression nor does depression induce smoking (Kendler et al., 1993). 
Another study found that smokers with a history of depression are more likely to fail at quitting 
as compared with those without a history of depression (Glassman, 1993; Covey, Glassman, 
Stetner, 1997). 
Similar association was found with heavy cigarette smoking during adolescence with an 
increase in various anxiety disorders at age 22 even after controlling for confounding factors 
(Johnson, 2000). In the same study, agoraphobia, generalized anxiety disorders and panic 
disorder, was also found associated with past history of cigarette smoking, but obsessive-
compulsive or social anxiety disorder was not associated with past history of cigarette smoking. 
In contrast to earlier studies, this study finds that adolescents with anxiety disorders may not be 
at elevated risk for chronic smoking during early adulthood. On the other hand, smoking 
abstinence was actually found to reduce the anxiety level of the individuals (West & Hajek, 
1997). This suggests that anxiety disorder was associated with past history of cigarette smoking 
and the anxiety decreased after the person stopped smoking cigarettes. 
In addition to the social factors, few studies have evaluated the genetic factors as 
determinants of co-morbid rates of smoking in psychiatric disorders and substance-use disorders 
(Kendler et al., 1993; Swan et al., 1996). For example, Leonard and Bertrand reported fewer 
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nicotinic receptors in individuals with schizophrenia and they postulated that it is due to 
abnormal genes that relate to neuronal nicotine receptors resulting in higher rate of cigarette 
smoking in these individuals (Leonard and Bertrand, 2000). Another common genetic 
predisposition to both smoking and depression was found in a large female twin study (Kendler, 
1993), which strongly suggests the biological vulnerability of smoking with mental illness. In 
addition to cigarette smoking, the genetic vulnerability is also cited as the main reasons for the 
co-morbidity to many psychiatric and substance- use disorders (Kendler et al., 2003).  
In summary, there is some evidence to support the likelihood of developing anxiety 
disorder or schizophrenia with cigarette smoking. However, the risks of developing mental 
illness with tobacco use or vice versa are highly debatable. More research is needed in this area 
to establish a causal relationship between these two conditions. 
2.5  Prevalence of cigarette smoking in different age groups 
The review of available literature failed to find the data on the prevalence of cigarette 
smoking among different age groups in individuals with mental illness. However, as discussed 
earlier, a close association exists between the age of initiation of cigarette smoking and the onset 
of mental illness. It was also noted that the quit rates in individuals with mental illness is low. 
Therefore, we can expect that the prevalence of cigarette smoking among different age group 
will be proportionally similar to all of the population. The data obtained from Canadian Tobacco 
Usage Monitoring Survey (CTUMS) in 2006 showed that the highest prevalence of cigarette 
smoking is between the ages of 20 and 24. The prevalence of smokers by age group is shown 
below in Table 1.  
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Table 1. Percentage of Smokers in different age groups in both sexes, Source Canadian 
Tobacco Usage Monitoring Survey, 2006
Age Group Percentage of Smokers 
15 ~ 19 14.8 
20 ~ 24 27.3 
25 ~ 34 23.9 
35 ~ 44 19.8 
45 ~ 54 22.0 
55 + 11.1 
 
The smoking prevalence among different age groups shows that the proportion of 
smokers increases up to the age of 24 and then declines slowly. It peaks again between the age of 
45 ~ 54 and then declines to the lowest after the age of 55 years. There are various reasons 
attributed to the peaks and falls of the smoking prevalence among general population, however, 
we have almost no data to understand how this prevalence is affected in smokers with mental 
illness. It will be interesting to compare the age-related prevalence of smoking among these 
individuals.  




There is a gradient in cigarette smoking prevalence with respect to occupational class, 
lone parents, unemployment and mental illness (Jarvis, 2006). Various studies have found a 
connection between current cigarette smoking and all these factors individually. Smoking 
prevalence is higher among the poorest and lowest among the most affluent (Jarvis, 2006). A 
deprivation score was calculated using General Household Survey data from the UK and by 
assigning a score of 1 for each of the following: occupational class, rented housing, no car, 
unemployed, living in crowded conditions. The resulting index had a score ranging from 0, 
among the affluent, to 5 among the poor. It was found that the level of nicotine dependence 
(calculated by saliva cotinine) was directly related with a higher deprivation score. For a 
deprivation score of 0, the level of cotinine was found 250ng/ml and it increases to 280, 300 and 
320ng/ ml for a deprivation score of 1, 2 and 3 respectively.  
Individuals with mental illness, as with any other chronic illness, are more likely to score 
high on the deprivation score used by Jarvis. It is due to the fact that the score is further 
compounded by the mental illness of the individuals and their smoking status. The association of 
mental disorders with low socio-economic status is not new. In a book by Shaw & McKay 
(1942), a consistent pattern of association was found between juvenile delinquency rates and 
poor housing, poverty, concentration of foreign-born, prevalence of tuberculosis, and prevalence 
of mental disorders. Another study carried out in New Zealand found that social and childhood 
factors were closely related to either nicotine dependence or depression (Fergusson et al., 1996). 
The study was carried out in a cohort of 16-year-old New Zealanders, and it examined 
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depression and nicotine dependence and prospectively measured risk factors including socio-
demographics, family history of criminality, life events, etc. These findings suggest that there 
may be some connection between likelihood of mental illness and cigarette smoking with factors 
such as occupation, class, and other living conditions as well. The relationship is far more 
complex than it seems, however, at present there is limited data to understand the true 
association between these two factors i.e., tobacco smoking and mental illness with social 
factors. More research is needed to further explain these associations. 
2.7  Cigarette smoking and cognition 
The effect of cigarette smoking exerted by nicotine is thought to improve the psychiatric 
symptoms of some of the individuals. In a study it was shown that the cognitive functioning of 
people with dementia improved after a short term of nicotine administration (Le Houezec, 1998). 
In the same study, improvement of Tourette’s syndrome was also demonstrated following 
nicotine administration. Similarly, in another study, the long-term nicotine administration in the 
form of nicotine patch improved the symptoms of Parkinson’s disease (Le Houezec, 1998). 
These findings suggest that cigarette smoking is also being used to overcome some of the 
psychiatric symptoms, whether due to the use of antipsychotic medications or due to their 
psychiatric diagnosis. There is still very limited evidence to support these effects and more 
research is needed in this area.  
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2.8  Tobacco use as a means of socialization 
Cultural acceptability is another major issue that is linked to smoking in many health 
institutions. Traditionally, psychiatric institutions condoned smoking, by using cigarettes as 
incentives, rewards, or punishments (McNeill, 2001). Some individuals use cigarette smoking as 
a means to socially interact with each other. Research has also shown that smoking is a form of 
social activity in mental health facilities and some of the staff even smoke with patients as a way 
of social interaction and to facilitate communication (Smoke free London, Mentality and ASH 
symposium, 2001). As a result of that interaction with staff as a condoned social activity, some 
individuals were introduced to smoking. As a result, they enter the facility as a non-smoker but 
leave as a smoker. Therefore, it is possible that, as a result of this social interaction, the 
prevalence of cigarette smoking may be higher in these individuals.  
2.9  Tobacco control policies in mental health settings 
The issue of tobacco control warrants attention, in terms of policies for individuals with 
mental illness, due to its strong correlation with specific mental illnesses and health conditions of 
the individuals. Despite the scope of this problem, tobacco use is largely ignored, deferred, or 
discouraged in the mental-health and addiction-treatment settings (Foulds, 1999; Rustin, 1998). 
The issue of cigarette smoking, unlike any other acute psychiatric symptom or addiction, has 
raised limited concerns especially at the policy level. It is likely that the issue is ignored because 
of lack of research and limited knowledge about the complexities surrounding tobacco usage in 
this group. Earlier studies have shown that rather than working effectively for tobacco control, 
some treatment settings have promoted the use of cigarettes as a behavioral reinforcement to 
An Epidemiological Analysis of smoking and smoking cessation 
 17
reward appropriate behaviors (Williams & Ziedonis, 2004). 
Canadian Federal Tobacco Control Strategy (FTCS) has identified key strategy areas for 
effective tobacco control in Canada. The FTCS has four mutually reinforcing components: 
protection, prevention, cessation, and harm reduction. The FTSC is supposed to target all 
Canadians, and the high risk groups identified are youth (smoking rate is 25%), young adults 
(32%), Inuit people (72%), First Nations people (62%) and other aboriginal groups (FTSC, 
2002). The prevalence rate in individuals with mental illness exceeds the national average and in 
some of the cases also exceeds the high risk groups identified in FTSC.  
Lack of advocacy for this group has also been a major factor in attempting to control 
tobacco usage in this population. Families and treatment providers have been ambivalent and 
showed little interest in tobacco control efforts on behalf of their loved ones and clients 
(Williams & Ziedonis, 2004). Mental health facilities and the policies governing them have been 
reluctant to address this issue despite these problems (Himelhoch & Daumit, 2003; Hughes, 
1997). Tobacco rations were an assumed part of day-to-day life in many such institutions 
(Shlomowitz, 1990). Some of the researchers have suggested that the mental health professionals 
have expressed various concerns while addressing the issue of cigarette smoking among 
individuals with mental illness (Hughes, 1997; Covey, Glassman & Stetner, 1997). They 
postulated that the mental health professionals do not accept the fact that mental health patients 
can succeed in quitting smoking. This could be either due to the fear of exacerbation of 
symptoms during nicotine withdrawal or due to the fear of reimbursement (Hughes, 1997; 
Covey, Glassman, & Stetner, 1997). As a result of these factors, this group is more exposed to 
environmental tobacco smoke as compared to the general non-psychiatric population. 
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Cigarette smoking is a deeply rooted issue that has grown over the centuries with the 
development of asylums and their evolution into current psychiatric in-patient facilities.  The 
immediate and long term benefits of addressing tobacco dependence among individuals with 
mental illness are often underestimated, and as a result, individuals with mental illness continue 
to smoke cigarettes. Strong public health policies should be developed to create environments 
conducive to the reduction of smoking rates in this group. 
2.10  Quit rates among individuals with mental illness 
Based on the available findings and review of the literature, addressing the issue of 
controlling tobacco usage in individuals with mental illness is among the lowest of priorities for 
the mental health professionals. In one of the studies, the spontaneous cessation rate for people 
with mental illness and addictions was found to be extremely low (Ziedonis and George, 1997). 
Interestingly, there is also some evidence to indicate that many individuals with mental illness 
and addictions want to reduce the amount that they smoke, or stop smoking altogether 
(Addington et al., 1997; Carosella et al., 1999; Forchuk et al., 2002; Goldberg et al., 1996).  In 
support of this finding, another study found that individuals with schizophrenia recognize 
smoking as a problem and they are also interested in attending smoking cessation groups and 
appear to be appropriately motivated (Addington et al., 1997; Ziedonis et al., 1997). 
In contrast to the above findings, some of the research has shown that despite the 
willingness to attend smoking cessation programs, quit rate among individuals with mental 
illness is low as compared to the general non-psychiatric population. For example, the National 
Comorbidity Survey data from the USA shows that persons with a history of mental disorder 
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such as depression, anxiety, or substance-use disorder, and especially those who had a mental 
disorder during the last four weeks, comprised a higher percentage of current smokers with lower 
quit rates (Lasser et al., 2000). Similar to this finding, a population-based survey found that 
smokers with higher depression scores (Center for Epidemiological Studies Depression Scale, 
CES-D) were less likely to quit nine years later compared to smokers who were non-depressed at 
baseline (Anda et al., 1990).  
The quit rate is also dependent on the concurrent use of addictive drugs in this group. The 
review of literature shows that individuals with concurrent addictions have more extensive 
histories with cigarettes, express attitudes reflecting less readiness to quit, and have higher rates 
of co-morbid psychological problems than those without addictions (Burling et al., 1996; Fogg et 
al., 2001). The likely explanation for this finding is the prolonged exposure and a higher 
dependency of tobacco. Another plausible explanation for the low quit rates in individuals with 
concurrent substance-use disorder the fact that this population represents a qualitatively or 
quantitatively different subset of smokers for whom specialized population-specific smoking 
treatments are needed (Burling et al., 1997). The review of the research in this particular area is 
somewhat inconclusive. The main drawback of this research was the non-availability of smoking 
cessation programs specially designed for this population.  
The pertinent issue associated with tobacco smoking, in individuals with mental illness, is 
the dilemma between the desire to quit, availability of cessation programs, biological 
dependence, and success rates for quitting. The result of this dilemma is high smoking 
prevalence among these individuals. At the individual level, these individuals have similar 
concerns as the general population, such as addiction, fear of withdrawal, weight gain, and 
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failure (Goldberg et al., 1996; Killen et al., 1996; Orleans & Hutchinson, 1993). The additional 
challenges associated with the fear and success of quitting can be attributed to their psychiatric 
symptoms. In a case series, smokers with mental illness experienced an exacerbation of 
psychiatric symptoms while trying to quit or cut down (Dalack & Meador-Woodruff, 1996). On 
the other hand, most controlled study has found no change in the level of psychotic symptoms 
during smoking cessation treatment (Evins et al., 2001; Weiner et al., 2001; Ziedonis et al., 
2003). The other important contributory factor in failure of the cessation can be attributed to 
nicotine dependence and its effect on the body in terms of affecting neurotransmitters throughout 
the body. 
 Although there is limited evidence to support the availability of smoking cessation 
programs especially designed for these individuals, the available literature also suggests that the 
mental health professionals have expressed their specific concerns while addressing the issue of 
smoking cessation. For example, they are concerned whether psychiatric patients can be 
prevented from smoking without major behavioral consequences (Geller & Kaye, 1990). For 
them, patients are generally viewed as too anxious and agitated while in acute psychiatric 
distress to be able to tolerate the added stress and frustration of nicotine withdrawal (Bronaugh & 
Frances, 1990). Mental health staffs view smoking-related problems as inappropriate attention 
seeking behavior, increase in surreptitious smoking, and other disruptive behavior (Patten, 
Martin, & Owen, 1996). Treatment staff frequently anticipates an increased need for seclusion, 
restraints, and PRN (as needed) medications (Beemer, 1993). Staff also sympathize with patients 
who have   already had everything taken away, and they don’t want to take the only pleasurable 
activity (smoking) away from them (Beemer, 1993). However, in a meta-analysis conducted by  
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Lawan & Pols, it was shown that these staff  members anticipated more problems after enforcing 
such restriciton on tobacco-dependent individuals (Lawn and Pols, 2005). The study also found 
that there was no increase in aggression, discharge against medical advice, or increased use of 
as-needed medication following the ban. 
The lack of research in this area is related to various factors discussed earlier, but most 
importantly, it is the lack of attention and consequently a lack of knowledge about this special 
group at different levels. More research is needed in this area to understand the characteristics of 
the individuals that would help them quit smoking, so that appropriate cessation program can be 
developed for them.  
2.11  Tobacco control in Ontario 
The acute care hospitals in Ontario have already placed a complete ban on cigarette 
smoking within their premises. On the other hand, individuals are allowed to smoke cigarettes in 
designated spaces within some of the nursing homes, long term care facilities, and mental health 
facilities. Beginning June 2006, the province of Ontario has implemented a smoke-free act which  
enforces a complete ban on smoking in all enclosed public facilities. Although the policy still has 
some provisions that exclude psychiatric facilities if they meet certain conditions, it is thought to 
be the first step towards addressing the issue in a broader perspective. The exclusion of 
psychiatric facilities, with certain provisions, actually points out that despite this evidence 
(discussed earlier), mental health professionals have their concerns towards enforcing a complete 
smoking ban within the facilities. 
Some mental health facilities in Ontario are working hard for tobacco control on behalf of 
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these individuals. Some are even providing assistance to help these individuals quit cigarete 
smoking. It is essential to put a system in a place to help individuals, in the best possible ways, to 
achieve better health outcomes.  
2.12  Summary of knowledge and current research questions 
In summary, it is clear that there are strong relationships between tobacco use and mental 
illness, and that this relationship has important implications for the health of the individual with 
mental illness as well as the general population of smokers (since persons with mental illness 
constitute a large proportion of tobacco control burden). However, it is also clear that there is 
much to learn. There are several significant gaps in our current knowledge. This thesis has been 
designed to address several of these gaps. Specifically, it will examine the following research 
questions. 
Q1. Who are the smokers within mental health institutions in Ontario? 
Understanding the social epidemiology of smokers can help in identifying the characteristics 
of a typical smoker admitted to a mental health facility in Ontario. These characteristics include 
i. Distribution of smokers 
ii. The effect of gender on smoking status 
iii. The effect of marital status on smoking status 
iv. The effect of age on smoking status 
v. The effect of being an aboriginal with smoking status 
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vi. The type of mental health units and the distribution of smokers 
vii. The reasons for admission 
viii. Area of primary residence 
ix. Level of education 
x. The relationship between psychiatric diagnosis and smoking status 
xi. The relationship between various types of anxiety and the individual’s smoking status 
xii. Social support available to smokers 
xiii. Social events and their relationship to smoking status 
xiv. Health complaints exhibited by individuals with respect to smoking status. 
xv. Hospitalization history and its relationship to smoking status 
xvi. Level of aggression in smokers and non-smokers 
xvii. Pain scale, positive symptoms scale, negative symptoms scale, and cognitive 
performance scale and its relationship with smoking status.  
Q2. Who receives smoking cessation programs? What are the determinants of receiving 
smoking cessation help?  
After developing controls for alcohol/ drug dependence and mental health facilities, 
characteristics of the individuals who were offered the treatment for “alcohol/ drug treatment/ 
smoking cessation” was explored. These characteristics may include the social epidemiologic 
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variables as well as other indicators such as health conditions, activity of daily living (ADL), 
violence, anger, mental state indicators, behavior disturbance, cognitive performance, etc. 
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3.0  Methods 
Secondary data analysis on the Ontario Mental Health Reporting System (OMHRS) was 
used to answer the research questions. The study received ethics clearance from the Office of 
Research Ethics, University of Waterloo, (ORE # 13824). 
3.1 Ontario Mental Health Reporting System (OMHRS) 
The Ontario Mental Health System (OMHRS) is a new system that includes clinical, 
administrative, and resource information to support inpatient mental health services planning in 
facilities with adult inpatient mental health beds in Ontario. It is used in every psychiatric bed 
throughout the province of Ontario. The system incorporates the Resident Assessment 
Instrument-Mental Health © (RAI-MH) instrument designed by interRAI (www.interrai.org), as 
well as admission and discharge tracking-related elements. The complete Ontario Mental Health 
System (OMHRS) data intake form is provided in Appendix A. 
RAI-MH © is a unique standardized data collection system for mental health that is 
designed to include care planning, outcome measurement, quality improvement and case mix-
based funding applications. The instrument includes a Minimum Data Set for Mental Health © 
(MDS-MH) with approximately 250 data elements. The distribution of these data elements helps 
to assess the various clinical domains, such as: 
• 28 items for Mental Health Assessment Protocols © (MHAPs) for care-planning  
• 32 items for Quality Indicators for Mental Health (QIMHs) 
• System for classification of In-Patient Psychiatry (SCIPP), the case-mix methodology 
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developed for use with the MDS-MH data. 
• Other outcome measures, such as Cognitive Performance Scale, Depression Rating Scale, 
Negative Symptoms Scale, Anxiety Scale, etc. 
The MHAPs, selected outcome measures, and QIMHs are described in Appendix B, C, 
and D, respectively. 
The psychometric properties of the interRAI outcome measures have been validated in 
different studies (InterRAI). These scales have been clearly researched to ensure that the 
measures are comparable to industry “gold standard” scales (InterRAI). The RAI-MH can be 
used to compare the needs of the mental health patients with individuals in other health care 
sectors, such as long-term care and home care, and allowing an integrated system for improved 
care. The triggering mechanism embedded in the RAI-MH can help identify imminent threat to 
the individuals, thus improving the care of the person.
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3.2  OMHRS and Tobacco Control 
The Resident Assessment Instrument has potential for research at many levels, starting 
from simple treatment issues up to the level of policy formulation. The instrument can also be 
used to understand the issues linked to cigarette smoking and mental illness. In addition to other 
clinical information and other variables, the OMHRS dataset includes variables to assess the 
smoking status of the individuals under section C5 (see Appendix A for the complete 




   0 – Daily 1 – Not in the last 3 days, but is a daily smoker 
   2 - Yes 
C5 Smoking Patient smoked or chewed tobacco daily 
Although the measure of smoking status is very crude, it can still be used to find the 
answers for many issues that are closely interrelated with cigarette smoking and mental illness. 
The principles underlying the development of this dataset are to focus on a broad range of needs 
that affect functioning and independence of the individuals. It also helps to measure the need and 
to organize information relevant to functioning in a way that supports, rather than replaces, 
clinical decision-making by mental health professionals (Hirdes, et al., 2000). It is also a broad 
screening instrument rather than an exhaustive assessment of any single clinical issue. Hence, 
although the instrument includes a series of items covering a broad range of common problems 
encountered in mental health, it is not intended to be a definitive assessment for addictions, 
eating disorders or post-traumatic stress disorder, for example (Hirdes, et al., 2000).  
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3.2.1  The Assessments Periods for OMHRS reporting 
The following record types and timeframes for assessment are required for OMHRS 
reporting: Figure 1 shows an illustration of the assessment periods. 
Admission Record  Within first 72 hours of admission to the adult mental health bed 
Short Stay Record  When the total length of stay is less than 72 hours 
Changes in Status Record Any major physical, mental, or social change that renders the last 
assessment data and care plan invalid 
Quarterly Record Within 92 days of the most recent admission, quarterly, or change 
in assessment 
Discharge Record Assessment at 72 hours before the patient leaves the inpatient bed 
and when there is no indication that the individual will be returning 
(that is, not a leave of absence) 
 














Short Stay Record – 
Released within 3 months 
since last assessment
Interruption of service 
OMHRS assessment 
Transferred to acute care 
Transferred to Rehabilitation  
Transferred to other facility 
Changes in Status Record 
Stayed more than 3 months 
since last assessment
Discharge Record 
No Readmission Readmission 
Figure 1: Life cycle of Ontario mental health reporting system 
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3.3   Participants 
All of the records of patients admitted in mental health institutions since 2005 are stored 
using the OMHRS. There were more than 80,000 assessments in the OMHRS database. Based 
on the study questions, only the first time assessment data (N=32449) was selected. The 
assessments were carried out during the period of October 2005 and September 2006. The 
analysis was carried out on the data information that was complete on variable C5, i.e., smoking 
status. However, even with the first assessment, there were some individuals who were admitted 
multiple times during the data collection period. Data was sorted, and all data was removed for 
the individuals who were admitted more than once (N=27282). 
   0 – No  1 – Not in the last 3 days, but is a daily smoker 
   2 - Yes 




Embedded within OMHRS are a number of outcome measures that cover clinical 
domains, ranging from clinical data to socio-demographic and administrative information. Based 
on the literature review and available socio-demographic information, the following variables 
were specifically analyzed.  
• Psychiatric diagnostic information (Q1) - Based on DSM-IV Provisional diagnostic 
category. The categories are ranked as “1” for most important diagnosis, “2” for the 
second most important, “3” for the third most important. 
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• Aggressive behavior scale (ABS_MH2) – The aggressive behavior scale is an indicator of 
the prevalence of aggressive behavior in the population being assessed. The scale is based 
on four items from the MDS-MH2 whose values range from 0 to 3. The scale is a 
summation of these items with a range of 0 to 12, where a higher score indicates a higher 
degree of aggressive behavior 
ITEMS DESCRIPTION 
E1b Verbal abuse 
E1c Physical abuse 
E1d Socially inappropriate or disruptive behavior 
E1f Resists Care 
• Indicator of Anxiety (B1O, B1P, B1Q, B1R, B1S, B1T) – specifically looking at the 
indicator exhibited within the last 3 days.  
SCORE DECRIPTION DESCRIPTION 
0 No pain I8a=0 
1 Less than daily pain I8a=1 
2 Daily pain, but not severe I8a=2 or 3 AND I8b=1 or 2 
3 Severe daily pain I8a=2 or 3 AND 18b=3 or 4 
 31
An Epidemiological Analysis of smoking and smoking cessation 
 32
• Pain (pain_MH2) – The scale uses two items on the (I8a and I8b) to create a score that 
ranges from 0 to 3 
• CAGE (CAGE_MH2) – The CAGE is a simple four-question yes/no screen that focuses 
on the consequences of drinking, rather than on the quantity or frequency of alcohol 
consumption. Every positive answer to this question is coded as 1 and then added 
together to give a final CAGE score. The questions are: 
C Have you ever tried to CUT DOWN on your drinking? 
A Have people ever ANNOYED you by criticizing your drinking? 
G Have you ever felt GUILTY because of something you did when you have been 
drinking? 
E Have you ever had a morning EYE-OPENER? (Taken a drink first thing in the 
morning?) 
• Social support networks (P1A-P1D) – This is described as the presence of one or more 
family members (or close friends) who are willing and able to provide the following 
types of support after discharge from formal care programs/ setting. 
DESCRIPTION ITEM 
Help with child care, other dependents P1a 
Supervision for personal safety P1b 
Crisis support P1c 
Support with ADLs or IADLs P1d 
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• Health complaints (B1CC) – This is described as, repetitive health complaints (e.g., 
persistently seeks medical attention; excessive concerns with bodily functions)  
• Psychotic symptoms scale (PSS_MH2) or positive symptoms of schizophrenia – It is 
based on four indicators of psychosis in OMHRS. These include hallucinations (item 
B1u), command hallucinations (item B1v), delusions (item B1w), and abnormal thought 
processes/ forms (item B1x). Each item is first coded as below, and then summed to give 
the positive/ psychotic symptoms scale (range 0 – 8). The higher scale indicates the 
severity of psychotic symptoms. 





• Negative symptoms of schizophrenia (NSS_MH2) – This is based on the negative 
symptom items in OMHRS. These include anhedonia (item B1y), loss of interest (item 
B1z), lack of motivation (item B1aa), and reduced interaction (item B1bb). Each item is 
first coded in the same manner as items in the positive/ psychotic symptoms scale, and 
then items are summed to give the negative symptoms scale (range 0 -8).  
• Cognitive performance scale (CPS_MH2) – The cognitive performance scale is a 
hierarchical index, used to rate the cognitive status of clients, and has been validated 
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against the Mini Mental State Examination and the Test for Severe Impairment (Morris et 
al., 1994; Hartmaier et al., 1995). 
CPS_MH2 is based on the scores of four items: F1a (short-term memory); F2 
(cognitive skills for daily decision making); H3 (expressive communication); G1e (eating 
self-performance). Based on the individual’s impairment level on these four items, a CPS 
scale ranging from 0-6 is derived. To calculate the CPS score, first an impairment count 
(impairment in table below) is created in which the score can take on values of 0, 1, 2 or 
3, depending on how many of the following conditions are met: 
• F2 = 1, 2 or 3 
• H3 = 1, 2, 3 or 4 and F1a = 1 
Next, a severe impairment score (‘severe impairment’ in table below) is 
calculated and it can take on values of 0, 1 or 2 depending on how many of the following 
are met: 
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CPS SCORE DESCRIPTION SPECIFICATION 
0 Intact F2 = 0, 1, 2, 3 AND impairment = 0 
1 Borderline Intact F2 = 0, 1, 2, 3 AND impairment = 1 
2 Mild Impairment F2 = 0, 1, 2, 3 AND impairment = 2, 3 AND 
severe impairment = 0 
3 Moderate Impairment F2 = 0, 1, 2, 3 AND impairment = 2, 3 AND 
severe impairment = 1 
4 Moderate/ severe impairment F2 = 0, 1, 2, 3 AND impairment = 2, 3 AND 
severe impairment = 2 
5 Severe impairment F2 = 4 AND H2g = 0, 1, 2, 3, 4, 5 
6 Very severe impairment F2 = 4 AND H2g = 6,8 
 
3.5  Data Cleaning 
The OMHRS database uses an electronic data entry system. The entry software has data 
checks that require the assessment items to be in the specified range of acceptable values (so an 
item that must be 0, 1 or 2 cannot have a response of 3). 
Completeness of the questionnaire is also considered, that is, questions cannot be left 
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unanswered. However, in spite of these procedures, it is difficult to conclude what is correct. 
Therefore, the study was restricted to assume that the recorded values are plausible. The major 
transcription error was minimized by using electronic data entry system software. 
Logical checks, (checking the data when the value of variables are reasonable and they 
depend on the value of some other variable), was conducted only in the case where observed 
values fail to satisfy our understanding about the outcome measures. Despite these checks, there 
was at least one assessment in which the age of the individual seemed doubtful, so individual 
assessments were removed from our analysis when age was our variable of interest. 
3.6  Data Analysis 
Question 1 – Who are the smokers? 
Dependent variable – Smoking Status (No, Yes, Not in the last 3 days but a daily smoker) 
The smoking data gathered using OMHRS cannot specifically separate current smokers 
from former smokers. The question related to smoking status asks whether the person smoked 
cigarettes daily, in last 3 days (but is a daily smoker), or did not smoke daily. The admission 
record (initial assessment) is done within 72 hours of admission to the adult mental health bed in 
Ontario. Based on the admission record, if a person was smoking a cigarette right before he got 
admitted, and had not had a chance to smoke since admission, and had not smoked in the last 
three days, he would be put into the category of a daily smoker. Based on clinical understanding, 
an individual who is admitted into a psychiatric unit in acute condition and requires prompt 
clinical action will find it difficult to smoke even if he or she wants to. For these reasons, both 
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these groups were collapsed into one single group and called smokers. 
• A range of univariate analysis was conducted (depending on the type of variables) on all 
the variables of interest. 
• Frequency tables were generated as a first step, to describe the distribution of data. 
• The frequency distribution obtained on all the variables of interest was carefully 
observed. 
• Bivariate analysis using cross tabs and χ2 test was used to explore the social 
epidemiology of smokers in relation to other variables of interest. 
• In addition to analyzing the difference between smokers and non-smokers in socio-
epidemiologic variables, the data was also analyzed to observe the differences in other 
variables of interests (described in earlier section) to specifically answer the study 
question. 
• Most of the variables were discrete and we used cross-tabulations, and chi-square to 
describe smokers’ and non-smokers’ socio-epidemiologic characteristics as well as other 
variables of interest. 
• Odds ratios were calculated using logistic regression modeling techniques to answer the 
research questions (psychiatric diagnosis) 
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Question 2 - Who receives smoking cessation programs? What are the determinants of receiving 
smoking cessation help? 
• As a first step, the confounding effect of substance-related disorder was controlled. 
• It was further controlled using diagnostic specific information (variable Q1D).  
• The concurrent substance use and excessive behaviors (variables C1, C2a, C2b, C2c, 
C2d, C2e, and C2f) was also controlled.  
• Exploratory analysis was done using socio-demographic information, psychiatric facility 
information, health conditions, activity of daily living (ADL), violence, anger, mental 
state indicators, behavior disturbance, cognitive performance, etc. 
• A similar statistical technique described earlier was used to answer the research 
questions. 




An Epidemiological Analysis of smoking and smoking cessation 
A total of 27,282 assessments were analyzed, based on their admission record data 
(intake form). Out of these assessments, 10,264 smoked or chewed tobacco daily (37.6%), 
whereas 2,381 individuals were assessed as daily smokers who had not smoked or chewed 
tobacco in last 3 days (8.7%) (Figure 2). The OMHRS admission record asks questions about the 
use of tobacco both in the form of smoke or chewed tobacco. According to Canadian Tobacco 
Use Monitoring Survey (CTUMS), the prevalence of recent use (i.e., use in the last 30 days) of 
smokeless tobacco (i.e., chewed or oral snuff) was 0.6% among those aged 15 or older in 2005. 
While it is acknowledged that tobacco use includes smokers as well as smokeless tobacco users, 
throughout this thesis the term smokers will be used interchangeably with the notion of tobacco 
use because the proportion of smokeless users is so modest.   
 
Figure 2: Smoking status of all individuals assessed at admission (N=27282)  
The smoking data gathered using OMHRS cannot specifically separate current smokers 
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from former smokers. The question related to smoking status asks whether the person smoked 
cigarettes daily, in last 3 days (but is a daily smoker) or did not smoke daily. The admission 
record (initial assessment) is done within 72 hours of admission to the adult mental health bed in 
Ontario. Based on the admission record, if a person was smoking a cigarette right before he or 
she was admitted and had not had a chance to smoke since admission, they would be placed into 
the category of a daily smoker, even if they had not smoked in last 3 days. Based on clinical 
understanding, an individual admitted into a psychiatric unit in an acute condition which 
requiring prompt clinical action, will find it difficult to smoke even if he or she wants to. For 
these reasons both these groups were collapsed to one single group and called smoker. 
The prevalence of smoking among individuals with mental illness who are admitted to 
mental health facilities in Ontario was significantly higher than the overall general population. 
After collapsing both types of smokers, the smoking prevalence was found to be extraordinarily 
high, (i.e., 46% of individuals within mental health institutions are smokers). The proportion of 
these individuals within mental health institutions is significantly higher than the national 
proportion of these individuals.  
4.1  Demographics 
Demographic data were analyzed using all the variables of interest to understand the 
demographic characteristics of all the individuals admitted to mental health institutions/facilities 
within Ontario between October 2005 and September 2006. The results of our demographic 
analysis were consistent with our expectations, based on our literature review and our 
understanding of the issues related to the relationship of smoking behavior in individuals with 




Admission were equally distributed by gender within the mental health institutions (i.e., 
approximately 50% of admission were male). There were 14 individuals who were labeled as 
‘Other’ in the gender category. Since these individuals are very low in number, about 0.04% of 
all the individuals (throughout the province of Ontario), and for the purpose of confidentiality, 
they were removed for all subsequent analyses.  
Smoking rates differed by gender.  Specifically, 58% of males were smokers, compared 
to 42% of females (a ratio of 1.38).   The fact that a larger proportion of males smoked is 
consistent with the patterns seen throughout the general Canadian population of adults where 
males are 1.42 times more likely to smoke than females.    
Marital Status 
Marital status of the sample is presented in Table 2. Forty eight per cent of individuals 
were never married, and they constituted the largest group. The data was stratified to show the 
effect of gender on marital status and smoking status. A higher proportion of males in the ‘never 
married’ category were smokers. Females who were married and widowed were least likely to be 
smokers, 30% and 20% respectively. In terms of males, divorced and widowed were least likely 
to smoke, 9% and 28% respectively.   
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Table 2. Smoking status by marital status
Marital Status  Smokers 
 N Female N (%) Male N (%) 
Never Married  13142 5168 (44.8) 7974 (56.4) 
Married 7068 4040 (30.4) 3028 (39.9) 
Partner/ Significant Other 930 500 (56.0) 430 (61.6) 
Widowed 1379 1067 (19.6) 312 (27.9) 
Separated 2168 1092 (52.7) 1076 (60.6) 
Divorced 2595 1508 (46.4) 1087 (57.8) 
 
Age 
The distribution of age within the data ranged from a minimum of 13 to a maximum of 
106 years of age. There was one observation of age shown as 0.5 showing a transcription error or 
data entry error. As of result of that error, it was removed from the calculation of mean age.  The 
mean age of the remaining individuals was 45 years with a standard deviation of 16.6. In terms 
of smoking status and age, the mean age of smokers (41 years) was significantly lower than non-
smokers (48)(p<0.001)). To look into the relationship of smoking status and age, the data was 
stratified into different age groups to see the proportion of smokers in respective age ranges 
(Figure 3). 





















19 ~ 24 years
(n=2433)
25 ~ 34 years
(n=5192)
35 ~ 44 years
(n=6113)





Figure 3: Smoking status by age group
Data was further stratified in terms of gender and is shown below in Table 3. Between the 
ages of 18 and 54 years, male smokers represented the largest group. The overall trend of 
smoking prevalence among male smoker increases steadily up to the age of 34 years and then it 
decreases with the increase in age. However, the prevalence of smoking among females up to the 
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Table 3. Smoking status by age group stratified by gender
Age Group  Smokers (%) 
 N Female Male 
Less than 19 years 587 36.0 43.9 
19 ~ 24 years 2433 47.1 55.6 
25 ~ 34 years 5192 48.6 60.6 
35 ~ 44 years 6113 45.8 57.9 
45 ~ 54 years 6095 44.8 59.0 
55+ years 6862 24.0 33.2 
 
Aboriginal Status 
The data was analyzed to evaluate the smoking prevalence among individuals with 
aboriginals status (i.e., originated from Inuit, Metis, or North American Indian). The result of the 
analysis is shown in Figure 4. Among all those admitted, 3% were classified as having aboriginal 
status. For individuals with aboriginal status, the smoking prevalence was found to be 72%, 
which was higher than individuals without the aboriginal status.  
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Figure 4: Smoking status by self identified Aboriginal origin (N=27282) 
Type of Mental Health Unit 
Mental health units in Ontario are divided into six different types. The distribution of 
individuals within these units was analyzed and is presented in Figure 5. Eighty one percent of 
individuals were admitted to Acute Units, and out of them, 45% of them were smokers. As 
expected, within the addiction unit, a higher percentage of individuals (75%) were smokers. 
These individuals made up 5% of all the admitted individuals in mental health facilities in 
Ontario.  
 45
An Epidemiological Analysis of smoking and smoking cessation 
Figure 5: Smoking status by type of mental health unit
 
Reason for Admission 
Data was analyzed to find the reason for admission of these individuals. Specific 
psychiatric symptoms (e.g., depression, hallucination, medication side effects) were the main 
reasons for admission in both the smokers and the non-smokers. Involvement with criminal 
justice system was the least likely reason for admission in both of the groups. Significant 
differences were found in reasons for admission in relation to an individual’s smoking status. 
Further data analysis was conducted after stratifying the data by gender. The result of the 
 46
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analysis shows that, even after controlling for gender effect, significant differences still exist in 
almost all the reason for being admitted into mental health institutions. The result of this analysis 
is presented in Figure 6.  
More females were admitted due to a threat or danger to self, inability to care for self due 
to mental illness, and specific psychiatric symptoms as compared to males. On the other hand, 
threat or danger to others, problems with addiction/ dependency, involvement with the criminal 
justice system, and others were the main reasons for admission among males. 
Threat or danger to self, and problems with addiction/ dependency, were the main 
reasons for admission among both male and female smokers. On the other hand, involvement 
with the criminal justice system and problems with addiction/ dependency was higher among 
female smokers. Similarly, among male smokers, problems with addiction/ dependency, threat or 
danger to self, involvement with the criminal justice system, and specific psychiatric symptoms 
was higher as compared to male non-smokers.  
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Figure 6: Smokers reasons for admission by gender (N=27,282)
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Area of Primary Residence 
Individuals were admitted to mental health facilities from across Ontario. In the analysis, 
primary area of residence was divided into five regions of Ontario based on the first three digits 
of their postal code. The result is presented in Table 4.  
The highest number of individuals (28%) came from Central Ontario, which consists of 
Parry Sound, Muskoka, Haliburton, Simcoe, Dufferin, Kawartha Lakes, Northumberland, 
Peterborough, Hastings, and Prince Edward counties. The result also shows the distribution of 
smokers is highest in Northern Ontario and lowest in Toronto, Ontario. 





Eastern Ontario 3120 47.0 
Central Ontario  7677 44.8 
Toronto, Ontario 5738 39.0 
Southern Ontario 6373 48.9 
Northern Ontario 1716 59.4 
Non-Ontarians 2658 51.4 
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Level of Education 
The smoking prevalence among individuals who had completed a graduate degree was 
low. On the other hand, those individuals who went to high schools and graduated have the 
highest smoking prevalence. Data was stratified by age to assess the potentially confounding 
effect of geriatric population in various age groups.  The result of the analysis is presented in 
Table 5. 
Table 5. Smoking status by level of education
Level of education Smokers 
N (%) 
< 65 years of age 
N (%) 
>65 years of age  
N (%) 
No Schooling 403 (37.9) 380 (94.3) 23 (5.7) 
8th Grade or less 766 (41.2) 661 (86.3) 105 (13.7) 
9 ~ 11 grades 3181 (58.3) 3069 (96.5) 112 (3.5) 
High Schools 3181 (49.3) 3088 (97.1) 93 (2.9) 
Technical or trade school 378 (47.7) 362 (95.8) 16 (4.2) 
Some College/ university 2033 (45.1) 1994 (98.1) 39 (1.9) 
Diploma/ Bachelors degree 1040 (37.6) 1007 (96.8) 33 (3.2) 
Graduate Degree 212 (28.2) 195 (92.0) 17 (8.0) 
Unknown 1451 (39.9) 1355 (93.4) 96 (6.6) 
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4.2 Psychiatric Diagnosis 
Psychiatric diagnosis was based on DSM-IV criteria (American Psychiatrist Association, 
2000) determined by the psychiatrists/ attending physicians and ranked in order of importance as 
factors contributing to this admission. Among both the groups, that is, smokers and non-smokers, 
the highest number of individuals had mood disorders as the most important diagnosis, followed 
by schizophrenia and substance-related disorders. The most common primary diagnosis within 
these individuals is presented in Figure 7, stratified by smoking status.  
In terms of differences in diagnosis (i.e., both most important diagnosis & any diagnosis) 
due to their smoking status, significant differences were found in most of the categories. The 
highest difference was found in substance-related disorders as expected, due to high correlation 
of smoking and other addictive disorder. 
Many individuals admitted to mental health institutions presented with multiple clinical 
issues and had multiple diagnoses. At the time of admission, the diagnosis that caused the 
individual to seek medical attention is more likely to be labeled as the most important or primary 
diagnosis. Data was analyzed to find out the diagnoses found in these individuals, irrespective of 
the level of importance identified by the psychiatrist or attending physicians. The result of this 
analysis is presented in Table 6.  
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Figure 7: Most common primary diagnosis by smoking status  
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Table 6. Smoking status by psychiatric diagnosis stratified by gender













Disorders of childhood/ adolescence1, 2 84 (29.8) 134 (26.9) 175 (33.1) 321 (36.8) 
Delirium, Dementia and other related 
conditions1, 2
525 (11.1) 610 (16.1) 881 (13.7) 876 (20.4) 
Mental disorders due to general 
medical condition1, 2
108 (28.7) 158 (26.6) 300 (31.7) 373 (32.7) 
Substance-related disorders1, 2 1335 (73.4) 2552 (74.4) 2525 (70.1) 4769 (72.9) 
Schizophrenia and other psychotic 
disorders 
3490 (37.5) 5018 (54.3) 3922 (37.6) 5517 (54.2) 
Mood disorders2 6499 (36.5) 4427 (47.0) 8065 (38.5) 6019 (49.9) 
Anxiety disorders1, 2 422 (38.9) 329 (43.2) 1843 (38.4) 1325 (46.5) 
Somatoform disorders 33 (36.4) 24 (45.8) 122 (38.5) 84 (47.6) 
Factitious disorders 3 (33.3) 4 (25.0) 10 (40.0) 12 (41.7) 
Dissociative disorders 26 (34.6) 12 (25.0) 93 (41.9) 30 (50.0) 
Sexual and gender identity disorders 0 (0) 22 (40.1) 9 (44.4) 75 (42.7) 
Eating disorders 188 (35.6) 7 (14.3) 416 (37.3) 31 (35.5) 
Sleep disorders 3 (33.3) 3 (66.7) 129 (44.2) 109 (44.0) 
Impulse-control disorders1, 2 46 (26.1) 84 (32.1) 227 (41.9) 358 (50.3) 
Adjustment disorders 323 (39.3) 303 (52.5) 717 (40.7) 628 (49.7) 
Personality disorders1 290 (48.3) 220 (47.7) 1593 (47.6) 1284 (59.8) 
1 indicates significant difference in primary diagnosis due to smoking status after controlling gender effect by 
Cochrane-Mantel statistics. 2 indicates significant difference in any diagnosis due to smoking status after 
controlling gender effect by Cochrane-Mantel statistics 
An Epidemiological Analysis of smoking and smoking cessation 
 54
Significant differences in primary diagnosis, as well as any diagnosis with respect to an 
individual’s smoking status, were observed in the results. Interestingly, the diagnosis of delirium, 
dementia, and other related disorders including Impulse-control disorders, are more common in 
individuals who did not smoke, irrespective of their gender. On the other hand, substance-related 
disorder is more common in individuals who smoke cigarettes, irrespective of their gender. 
Logistic regression modeling technique was used to calculate the odds of smoking with 
respect to a particular psychiatric diagnosis. The model was adjusted to control the effect of 
gender and age. The reference group for this model was individuals with the diagnosis of 
Delirium, dementia, and other related disorders. This reference group was selected because the 
smoking prevalence was very close to the national average. Clinically, an individual with 
adjustment disorder does not differ much with the general population. However, in this study the 
smoking prevalence was very high compared to the national average. 
The model shows that individuals with the diagnosis of substance-related disorder are 
four times more likely to smoke cigarette as compared to the reference group. The result of the 
analysis is presented in Table 7 which includes childhood, delirium & dementia, mental disorder 
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Table 7. Probability of being a smoker with respect to their psychiatric diagnosis
Diagnosis Odds 
ratio 
95% CI Significance 
Delirium, Dementia and others (reference group) 1.000 - - 
Disorders of childhood/ adolescence1, 2 0.965 0.679 – 1.372 0.8434 
Mental disorders due to general medical 
condition1, 2
1.438 1.039 – 1.990 0.0286 
Substance-related disorders1, 2 8.987 7.422 – 10.882 <0.0001 
Schizophrenia and other psychotic disorders 2.863 2.384 – 3.438 <0.0001 
Mood disorders2 2.569 2.144 – 3.078 <0.0001 
Anxiety disorders1, 2 2.415 1.917 – 3.043 <0.0001 
Somatoform disorders 2.493 1.413 – 4.398 0.0016 
Factitious disorders 1.404 0.264 – 7.470 0.6907 
Dissociative disorders 1.674 0.820 – 3.417 0.1575 
Sexual and gender identity disorders 1.967 0.819 – 4.725 0.1304 
Eating disorders 1.580 1.112 – 2.243 0.0106 
Sleep disorders 2.440 0.481 – 12.374 0.2817 
Impulse-control disorders1, 2 1.306 0.858 – 1.990 0.2134 
Adjustment disorders 2.700 2.124 – 3.432 <0.0001 
Personality disorders1 2.870 2.231 – 3.693 <0.0001 
* Adjusted for gender and age 




Indicators of anxiety included anxious complaints, fears/ phobias, obsessive thoughts, 
compulsive behavior, intrusive thoughts/ flashbacks and episode of panic. The data were 
analyzed to specifically look at the indicators of anxiety, if they were exhibited in the last 3 days.  
Except for anxious complaints and Intrusive thoughts/ flashbacks, smokers did not 
exhibit anxiety in the last 3 days, which was found to be significant based on their chi-square 
statistics. The data were stratified to control the effect of gender (Table 8). The analysis showed 
that male smokers in general had more anxious complaints as compared with female smokers. 
Indicators of anxiety were significantly different in smokers and non-smokers even after 
controlling the effect of gender for fears/ phobias and compulsive thoughts. On the other hand, 
the significant difference due to smoking was also found among males for anxious complaints 
and Intrusive thoughts/ flashbacks. Among females, they also differ significantly for obsessive 
thoughts.  
Available Social Support 
Data was analyzed to assess the social support from one or more family members (or 
close friends) who are willing and able to provide assistance especially with childcare, personal 
safety, crisis support, and support with Activities of daily living (ADL) or Instrumental activities 
of daily living (IADL). Overall, less support was available for smokers in all the categories. 
More specifically, a low level of social support was available for smokers on a regular as well as 
occasional basis. The result of the analysis is presented below in Table 9. 
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Table 8. Smoking status by indicators of anxiety stratified by gender
Female Male Indicators of Anxiety 
N Smoker 
(%) 
N Smoker (%) 
Anxious complaints1 5291 40.7 4182* 55.1 
Fears/ phobias1 2957* 35.6 2135* 50.3 
Obsessive thoughts1 2615* 36.6 2379* 50.8 
Compulsive thoughts1 699* 35.5 700* 45.9 
Intrusive thoughts/ flashbacks1 1912 41.1 1489* 57.1 
Episodes of panic 1705 38.9 1059 52.12 
1 – Significant differences in smoking status after controlling gender effect based on 
Cochrane-Mantel-Haenszel statistics 
* - p<0.05 in their respective categories 
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Help with child care, 
other dependents 
46.4 46.2 43.9 47.7 
Supervision for 
personal safety1
50.0 37.1 47.5 48.8 
Crisis support1 47.3 42.7 47.8 49.1 
Support with ADLs or 
IADLs1
49.6 33.6 43.7 47.2 
1 – p<0.0001 based on chi-square statistics 
Social Relationships 
Data was also analyzed to understand the social relationship of the individuals that 
occurred in various time periods, i.e., in last 3 days, last week, last month, or more than one 
month ago. Significant differences were observed between smokers and non-smokers in all three 
types of social relationships. Generally, smokers experienced limited social contacts of long-
standing interest, especially in last 3 days. The result of the analysis is shown in Table 10. 
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Table 10. Smoking status by Social relationship activities









Participation in social activities 
of long-standing interest 
(p<0.0001) 
8255 (46.0) 4208 (50.3) 5938 (46.8) 8881 (44.6) 
Visit by a long-standing social 
relation/ family member 
(p<0.0001) 
16400 (43.2) 4506 (51.0) 2605 (51.3) 3771 (51.1) 
Telephone or email contact with 
long-standing social relation/ 
family member (p=0.001) 
18536 (46.2) 3574 (49.0) 1931 (46.4) 3241 (44.2) 
 
Health Complaints 
Data was analyzed to observe the differences in smokers and non-smokers in terms of 
their health complaints (e.g., persistently seeking medical attention; excessive concerns with 
bodily functions). Initial analysis showed that smokers have fewer health complaints in the last 3 
days as compared to non-smokers (p=0.0692). Data was stratified and analyzed using Cochrane-
Mantel-Haenszel statistics to control the effect of gender. The result showed that male smokers 
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had more health complaints as compared to non-smokers, but the results was non-significant 
(p=0.92). On the other hand, female smokers exhibited fewer health complaints. The result of the 
analysis is shown in Table 11. 
Table 11. Smoking status by Health complaints exhibited in last 3 days stratified by gender
Female Male Health complaints 
N Smoker (%) N Smoker 
(%) 
Not exhibited in the last 3 days 10086 39.7 11437 52.8 
Not exhibited in the last 3 days, but is 
reported to be present 
396 35.1 389 53.2 
Exhibited 1 – 2 of the last 3 days 1438 41.2 1063 54.1 
Exhibited daily in the last 3 days 1455 39.1 1018 51.5 
               
Hospitalization History 
In terms of using resources, the data was analyzed to see how smokers differ from non-
smokers. Data analysis was carried out to discover the number of psychiatric admits (recent), 
number of psychiatric admits (lifetime), time since last discharge, amount of time hospitalized, 
contact with community mental health, and age at first hospitalization,. The result of these 
analyses is presented in tables 12, 13, 14 and 15. 
An Epidemiological Analysis of smoking and smoking cessation 
 61
Table 12. Smoking status by Number of recent psychiatric admissions
Female Male Number of Psychiatric 
Diagnoses (Recent) 
N Smoker (%) N Smoker (%)
None 6950 36.3 7256 49.0 
1 ~ 2 4390 41.5 4692 54.4 
3 or more 2035 47.4 1959 62.9 
          p<0.0001 
The results of the analysis show that male smokers have a significantly higher number of 
recent psychiatric admissions as compared to male non-smokers. However, female smokers have 
fewer numbers of recent psychiatric admissions. 
The lifetime duration of hospitalization, including time since last admission, in 
psychiatric hospital/ unit in the last 2 years, and contact with community mental health centres, 
all show similar patterns, as described in recent psychiatric admissions. Male smokers had more 
history of using mental health services. On the other hand, female smokers used relatively less 
mental health services. All the results were significant after controlling for gender effect, based 
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Table 13. Smoking status by Number of psychiatric admissions (lifetime) 
FEMALE MALE Number of psychiatric 
admissions (lifetime) 
N Smoker (%) N Smoker (%) 
None 4408 34.2 4941 46.5 
1 ~ 3 4638 38.4 4910 52.8 
4 ~ 5 1751 41.5 1782 57.1 
6 or more 2578 50.2 2274 63.0 
          p<0.0001 
Table 14. Smoking status by Time since last discharge
Female Male Time Since Last Discharge 
N Smoker (%) N Smoker (%) 
More than 1 year 4565 40.1 4359 54.0 
31 days to 1 year 3067 44.1 3146 58.2 
30 days or less (from other facility) 889 45.3 980 57.9 
30 days or less (from this facility) 446 47.8 481 60.5 
Not applicable 4408 34.2 4941 46.5 
p<0.0001 
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Table 15. Smoking status by Duration of hospitalization
Female Male Duration of hospitalization 
N Smoker (%) N Smoker (%) 
No other admission in last 2 years 6950 36.3 7256 49.0 
30 days or less 3682 43.7 3772 58.3 
31 days to 1 year 2385 43.2 2416 56.2 
More than 1 year 358 40.8 463 48.8 
p<0.0001 
Table 16. Smoking status by Contact with Community Mental Health
Female Male Contact with community mental 
health 
N Smoker (%) N Smoker (%) 
No contact in last year 5943 37.7 6715 49.9 
31 days ore more 2375 43.7 2532 56.0 
30 days or less 5057 40.1 4660 55.1 
p<0.0001 
Data analysis, in terms of age at first psychiatric hospitalization and current smoking 
status, showed an interesting pattern. The current smoking status of males who had their first 
psychiatric admission between the ages of 15 ~ 44 are proportionally higher as compared to non-
smoking males. On the other hand, no particular trend is noted among female current smokers 
and early psychiatric hospitalization. However, with female smokers, the highest proportion of 
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female smokers had their first admission between the ages of 15 and 24. It is also worth noticing 
in all the age groups that the mean age of smokers is lower as compared to the non-smokers. The 
result of the analysis is presented in Table 17.  
Table 17. Smoking status by age of first psychiatric hospitalization
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Outcome Scales 
The data was analyzed to see how smokers differ from nonsmokers in terms of various 
outcomes scales embedded within OMHRS. Specifically aggressive behavior scale, positive/ 
psychotic symptoms scale, negative symptoms scale, pain scale, cognitive performance scale, 
and depression rating scale were analyzed. The result of the analysis is shown in Table 18, 19, 
20, 21 and 22. 
Table 18. Smoking status by Aggressive behavior scale
Aggressive Behavior Scale Female Male 
 N Smoker 
(%) 
N Smoker (%) 
No aggression to mild 
aggression (0 ~ 4) 
12058 39.6 12566 53.2 
Severe (5+) 1317 40.5 1341 48.8 
          p=0.08 
Results of the analysis shows a consistent trend, i.e., 90% of the individuals are classified 
as ranging from no aggression to mild aggression in both the genders. However, a gender effect 
was found in the scale. Among those classified as having no aggression to mild aggression, male 
smokers were slightly higher in proportion (53%) as compared to female smokers (40%). 
Similarly among those classified as having severe aggression (5+), male smokers were in higher 
proportion as compared to female smokers (49%).  
In terms of pain, proportionally, male smokers had more pain in all scale categories as 
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compared to male nonsmokers. However, comparing the proportion of individuals who 
experienced less than daily pain to severe daily pain, males experienced less pain as compared to 
the females.  
Table 19. Smoking status by Pain scale








No pain 73.8 37.3 79.8 50.9 
Less than daily pain 11.5 43.8 8.8 57.2 
Daily pain, but not severe 11.5 48.2 8.8 61.4 
Severe daily pain 3.2 49.7 2.6 66.1 
p<0.0001 
In terms of positive symptoms scale, 15% of the individuals were in a moderate to severe 
scale. Within those in the moderate to severe category, 46% were smokers as compared to 54% 
of non-smokers. The stratified analysis of data, with respect to gender, shows that the proportion 
of male smokers is higher, with moderate to severe positive symptoms, as opposed to the female 
smokers, whose proportion is less in a moderate to severe positive symptoms scale. The result of 
the analysis is shown in Table 20.   
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Table 20. Smoking status by Positive symptoms scale 
Females Males Positive Symptoms Scale 
N Smoker 
(%) 
N Smoker (%) 
None to Mild (0 ~ 3) 11420 40.4 11676 52.5 
Moderate to severe (4 ~ 8) 1955 35.7 2231 54.4 
p=0.1646 
The relationship of smoking status with the negative symptoms scale is also pretty much 
consistent with the positive symptoms scale. However, 27% of the individuals had moderate to 
severe negative symptoms. Within the group of individuals with moderate to severe negative 
symptoms, 42% were smokers. The gender stratified analysis of the individual shows that 35% 
of the female smokers were in a moderate to severe category as compared to 49% of male 
smokers. The result of the analysis is shown in Table 21. 
Table 21. Smoking status by Negative symptoms scale 
Females Males Negative Symptoms Scale 
N Smoker (%) N Smoker (%) 
None to Mild (0 ~ 3) 9389 41.6 10471 53.9 
Moderate to severe (4 ~ 8) 3986 35.0 3436 49.4 
         p<0.0001 
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 In terms of the cognitive performance scale, a majority of the individuals scored low, i.e., 
their cognition is intact. However, when it is stratified by gender and smoking status, high 
proportions of smokers have better cognition level as compared to non-smokers. As the level of 
impairment increase, the proportion of smokers decreases. The overall effect is the same for 
males and females, but the effect is more pronounced among male smokers. The result of the 
analysis is shown in Table 22. 
Table 22. Smoking status by Cognitive performance scale 
Female Male Cognitive Performance 
Scale 
N Smoker (%) N Smoker (%) 
Intact 8263 43.2 8732 56.6 
Borderline Intact 2586 39.4 2699 52.6 
Mild Impairment 612 38.1 622 48.7 
Moderate Impairment 1235 28.1 1162 44.8 
Moderate/ severe 
impairment 
183 24.0 181 30.9 
Severe impairment 414 20.1 416 20.0 








The second major question in this thesis is to assess who gets the alcohol/ drug treatment/ 
smoking cessation treatment in mental health institutions in Ontario. In the OMHRS dataset, 
there is only one question that asks about focus of treatment intervention. In the case of the 
research questions, it was Alcohol/ drug treatment/ smoking cessation. Since the question, 
doesn’t differentiate whether the person is getting an intervention for alcohol, drug treatment or 
smoking cessation, in order to remove the confounding effects, new dataset was created with 
different combinations to see how the pattern changes.  
First the data was analyzed after deleting the entries for those who drink alcohol and 
those with drug problems. The result of the analysis shows that there was no focus of 
intervention for alcohol/ drug treatment/ smoking cessation for the majority of the smokers 
(without any co-existing substance use or alcohol problem). The data was further analyzed to 
find a focus for intervention (alcohol/drug treatment/ smoking cessation) in relation to smoking 
status, by combining data from all the individuals, irrespective of their smoking, drug, or alcohol 
problem. The study found that 88.9% of the smokers, with or without co-existing drug or alcohol 
problem, didn’t have a focus of intervention directed towards alcohol/ drug treatment/ smoking 
cessation. Similarly, 76% of the smokers without alcohol problems, and 69% of the smokers 
without drug problem, did not receive any alcohol /drug treatment/ smoking cessation 
intervention. Table 23, 24, 25 and 26 shows the results of these analyses.  
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Table 23. Focus of Intervention (Individuals without any alcohol or drug problems) 













No Intervention of this type 97.6 92.1 96.4 88.9 
Offered, but refused 0.3 1.2 0.3 1.8 
Received in last 7 days 1.5 5.6 2.6 7.9 
Not received, but scheduled to start 
within 7 days 
0.6 1.0 0.8 1.5 
 
Table 24. Focus of Intervention (Individuals without any drug problems) 













No Intervention of this type 95.5 85.2 92.8 79.1 
Offered, but refused 0.5 1.8 0.6 2.5 
Received in last 7 days 3.2 11.1 5.5 15.5 
Not received, but scheduled to start 
within 7 days 
0.8 2.0 1.1 3.0 
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Table 25. Focus of Intervention (Individuals without any alcohol problems) 













No Intervention of this type 96.3 84.6 93.9 79.1 
Offered, but refused 0.4 1.8 0.5 2.2 
Received in last 7 days 2.6 10.9 4.5 15.6 
Not received, but scheduled to start 
within 7 days 
0.7 2.7 1.1 3.1 
 
Table 26. Focus of Intervention (Irrespective of their alcohol or drug problems) 













No Intervention of this type 93.6 76.1 88.9 68.5 
Offered, but refused 0.6 2.3 0.9 3.4 
Received in last 7 days 4.7 17.7 8.5 23.4 
Not received, but scheduled to start 
within 7 days 
1.1 3.9 1.7 4.8 
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Further data analysis was conducted to find other correlates that may affect the focus of 
intervention, especially for alcohol/ drug treatment/ smoking cessation programs. Another 
dataset was created which included only smokers. Bivariate analysis was conducted to see the 
effect of potential variables in receiving the intervention. The results of all these analyses are 
presented in Tables 27 and 28. 
In terms of gender, more males were offered, received or scheduled to receive this 
intervention as compared to females (p<0.0001). There was almost no difference in interventions 
with respect to a person’s aboriginal status. In terms of marital status, more individuals who had 
a partner or significant others received the intervention as compared to other groups. Clearly, 
those who were widowed and never married were less likely to receive the intervention. 
In terms of activities of daily living, individuals who were independent were offered, 
received, or scheduled to receive the intervention as compared to those who either require 
minimal supervision or were dependent on others. Interestingly, those who were totally 
dependent were offered, received, or scheduled to receive the intervention. Similarly, individuals 
who scored ‘zero to mild’ on an aggressive behavior scale, positive symptoms scale, and 
negative symptoms scale were offered, received or scheduled to receive this intervention as 
compared to those individuals who were categorized as severe in all these scales. 
When it comes down to the relationship of provisional psychiatric diagnosis and 
intervention, substance-related disorder was the most likely group to receive the intervention, 
followed by adjustment disorders. However, the most common diagnosis among all the  
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Female (N=5306) 76.1 2.3 17.7 3.9 Gender 
(p<0.0001) 
Male (N=7339) 68.5 3.3 23.4 4.8 
No (N=9662) 73.6 2.5 15.8 3.1 Alcohol >5 drinks 
in any single 
sitting (p<0.0001) Yes (N=2983) 49.3 4.4 37.8 8.5 
No (N=12086) 71.6 2.9 21.1 4.3 Aboriginal 
(p=0.03) 
Yes (N=559) 72.8 2.9 17.9 6.4 
Independent (N=11258) 70.3 2.9 22.3 4.5 
Supervision required (N=697) 84.7 2.6 9.3 3.4 
Limited Impairment (N=265) 79.6 3.0 14.0 3.4 
Extra assistance required(I) (N=247) 85.4 3.6 8.1 2.8 
Extra assistance required(II) (N=97) 87.6 3.1 7.2 2.1 
Dependent (N=41) 90.2 0.0 2.4 7.3 
Activities of Daily 
Living (p<0.0001) 
Total Dependence (N=40) 50.0 7.5 35.0 7.5 
None to Mild (N=11457) 70.6 2.8 22.1 4.5 Aggressive 
Behavior Scale 
(p<0.0001) Severe (N=1188) 81.8 4.3 10.0 3.9 




Severe (N=1912) 84.1 3.2 9.2 3.6 
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None to Mild (N=9551) 71.1 2.8 21.9 4.2 Negative 
Symptoms Scale 
(p<0.0001) 
Severe (N=3094) 73.4 3.2 18.3 5.2 
Never married (N=6812) 73.2 3.0 19.0 4.8 
Married (N=2437) 69.9 2.3 24.3 3.5 
Parent/ significant other (N=545) 65.7 1.3 27.5 5.5 
Widowed (N=296) 79.7 2.4 15.9 2.0 
Separated (N=1227) 66.6 3.4 25.0 5.0 
Marital Status 
(p<0.0001) 
Divorced (N=1328) 72.5 3.9 19.8 3.8 
Delirium, Dementia and other (N=176), 
p=0.64 
72.2 4.0 21.0 2.8 
Mental disorder due to gen. med. 
condition (N=217)* 
86.2 1.8 9.7 2.3 
Substance disorders (N=5249)* 47.9 3.8 41.1 7.2 
Schizophrenia (N=4463)* 84.16 3.3 9.5 3.0 
Mood disorders (N=6112)* 75.6 2.7 16.6 5.1 
Anxiety disorders (N=1324), p=0.5 70.9 3.0 20.9 5.2 




Personality disorders (N=1526)* 76.9 3.7 14.4 5.1 
Non-dependent (N=7449) 89.1 2.1 6.7 2.1 Cage Addiction 
Score (p<0.0001) 
 
Dependent (N=5196) 46.8 4.1 41.5 7.7 
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individuals in mental health institutions in Ontario were mood disorders and schizophrenia. 
These members were among the lowest diagnostic group/least likely to receive the intervention. 
Individuals who had more than (>) 5 drinks of alcohol in any single sitting episode were 
offered, received, or scheduled to receive the intervention as compared to those who had less 
than 5 drinks. Similarly, individuals who scored higher on the CAGE addiction scale were 
proportionally higher in number to be offered, received or scheduled to receive the intervention.  
Data was also analyzed to seek the most common facility level for obtaining smoking 
cessation help; ten out of sixty-four of the facilities had no intervention at all for smokers 
(without any co-existing alcohol or drug problem). Different combinations of variables were 
used to understand the focus of intervention offered to these individuals by using smokers with 
co-existing drug problem, smokers with co-existing alcohol problem and smokers having both 
drug and alcohol problem.  
Logistic regression modeling technique was used to further analyze the relationship of 
smoking and intervention offered to individuals. Since the research questions were developed 
specifically for the smokers and we were interested in smokers only,, the model was designed to 
select individuals with current smoking status. Intervention options were analyzed by dividing 
them into two groups: no intervention or any intervention. Result of the analysis is presented 
below in Table 29. 
Clearly, it can be seen from the model that smokers who scored on CAGE addiction scale 
were four times more likely to receive the intervention as compared to those who didn’t score. A 
one point increase in the aggressive behavior scale will make a person 4% less likely to receive 
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the intervention. Similarly, an individual is 7% less likely to receive the intervention for a one 
point increase in activity based on the daily living scale, and  7% less likely to receive the 
intervention for a one point increase in positive symptom scale. On the other hand, it is 30% 
more likely for an individual to receive the intervention for a one point increase in negative 
symptoms scale.  
 
Table 29. Probability of receiving cessation intervention in smokers only 
Variable Estimate Odds 
Ratio 
Con. Interval 
Intercept -2.42   
Aggressive Behavior Scale -0.04 0.96 0.938 – 0.986 
Activity of daily living -0.08 0.93 0.867 – 0.990 
CAGE score 1.40 4.06 3.645 – 4.525 
Positive Symptoms Scale -0.07 0.93 0.907 – 0.962 
Negative Symptoms Scale 0.03 1.031 1.012 – 1.050 
 
 An interaction effect was found between smokers who were diagnosed with Substance- 
use disorder and those who had five or more drinks in one sitting. The odds ratio calculated, 
based on their interaction effect, is shown in Figure 8. It shows that the smokers who had more 
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than five drinks in one sitting without any substance-use disorder are less likely (OR=0.53) to 
receive the intervention. On the other hand, smokers with substance-use disorder who didn’t 
have more than five drinks in one sitting are more likely (OR=1.37) to receive the intervention. 
However, the odds of receiving the intervention are extremely high for smokers who had both 
these problems. 
 
Figure 8: The odds of receiving cessation intervention considering the interaction effect of 
having five or more alcoholic drinks and being diagnosed with substance use disorder (reference 
group is individual without substance use disorder and not having 5+ drinks in one sitting in last 
14 days) 
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5.0  Discussion 
To the best of our knowledge, this thesis is the single largest study not only in Canada but 
probably in the world to understand the characteristics of smokers in mental health institutions. 
This study is unique in the sense that it uses census data (with the exception of very few 
individuals) from all of the individuals who were admitted and stayed for at least 3 days in a 
designated mental health bed throughout the province of Ontario. The collected data can be 
considered as census level data, with some warnings. Since the dataset used for this study started 
at the beginning of the mandatory implementation, some of the facilities were delayed in getting 
up to full speed; therefore, it may be marginally different from a true census dataset in that the 
earlier months may exclude a few facilities. The other important consideration for this data is 
that it only assesses individuals who stayed as inpatients in psychiatric beds 3 days or longer, 
therefore, shorter term admissions were absent from this dataset. Despite these considerations, 
this is the most comprehensive and multidisciplinary mental health assessment data.  
The issue of tobacco control has gained significant attention throughout the world after 
the Surgeon General’s report. Various steps were taken since then to reduce the harmful effects 
of cigarette smoking. Results from representative national surveys indicate that the smoking 
prevalence rates have fallen from 35% to 19%. Despite this, over 5 million Canadians continue 
to smoke, and tobacco use remains the primary cause of preventable deaths among Canadians. 
The prevalence of tobacco use varies widely across various overlapping subpopulations. This is 
especially true for the individuals with mental illness where smoking prevalence is very high. 
The true extent of this problem has not received its due attention, probably due to limited 
research and lack of knowledge about the prevalence, etiology, consumption patterns and 
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treatment of tobacco.  
Some of the earlier studies have shown a wide range of smoking prevalence ranging from 
50% -90% among individuals with mental illness or addiction. The studies have also shown that 
rates vary according to co-occurring disorder diagnosis and setting of the study. Using the census 
level data for the analysis, the present study found smoking prevalence at 47%. This is in 
contrast to some of the earlier claims that found very high smoking rates in this population. The 
important methodological considerations between the present study and earlier study were the 
sample size, study population, and smoking measures. 
Ontario Mental Health Reporting System (OMHRS) was developed as a broad screening 
instrument rather than an exhaustive assessment of any single clinical issue. Hence, although the 
instrument includes a series of items covering a broad range of common problems encountered in 
mental health, it is not intended to be a definitive assessment for any single clinical issue. The 
data item for smoking status asks whether the patient smoked or chewed tobacco daily. There 
were three possible responses to that question: “1) No 2) not in last 3 days, but is a daily smoker 
and 3) Yes”. According to Canadian Tobacco Use Monitoring Survey (CTUMS) the prevalence 
of recent use (that is, use in the last 30 days) of smokeless tobacco (i.e., chewed or oral snuff) 
was at 0.6% among those aged 15 or older. There was no specific prevalence data of smokeless 
tobacco among individuals with mental illness. Because the prevalence rate of smokeless 
tobacco was very low for the purpose of this research, individuals were all classified as cigarette 
smokers. On a clinical note, while the health risks are lower than for cigarettes, a number of 
serious health consequences are associated with smokeless tobacco use, including an increased 
risk for oral cancer, and possibly other head and neck cancer (US Department of Health and 
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Human Services, 1992), soft tissue lesions including leukoplakia, and periodontal disease 
(Critchley J.A., 2003). Therefore, classifying these individuals in the category of cigarette 
smoker should not affect the conclusion of this research. 
The prevalence of smoking in this study was slightly lower (47%) compared to previous 
studies which showed a huge variation in smoking prevalence. This could be due to various 
factors, for example, since OMHRS uses a self-identified definition of smoker if the patient 
admits to smoking or chewing tobacco daily, the actual prevalence could be higher than the 
estimated prevalence. Another important consideration is the use of data from inpatients only. 
Most of the earlier studies have used the data from outpatient clinics. The other possible factor is 
the training of the interviewer completing the assessment and the interviewer understanding of 
the definition of smoker. However, the inter-rater reliability of OMHRS is pretty good, but as 
mentioned earlier, it is designed for broad screening rather an exhaustive assessment of any 
single clinical issue. As a result of this screening, it is more likely that the measure of smoking 
status is conservative and that the actual prevalence would have been higher if there were 
comprehensive questions specific to smoking-related problems.  
The other possible reasons for the low prevalence could be due to the type of mental 
health units. The majority of the individuals (81%) were admitted to acute units, followed by 
addiction units. The main reason for admission among these individuals was specific psychiatric 
symptoms followed by threat or danger to self. Based on the clinical understanding, it is likely 
that these individuals were in a state of psychosis and many of them were sedated, therefore, it is 
less likely for them to smoke and also for the interviewer to obtain correct information from 
them. All these factors points to the data in OMHRS as a conservative measure of the smoking 
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status among these individuals. Despite the conservative measure, the smoking prevalence is still 
three times higher than the general population. This very fact highlights the importance of taking 
appropriate measures for smoking cessation among these individuals. 
The high prevalence of tobacco smoking among individuals with mental illness is linked 
with other correlates of tobacco smoking and mental illness. This study tried to explain the 
correlates of tobacco smoking among these individuals. The demographic characteristics, social 
factors, and psychiatric diagnoses were studied. 
Population Demographic Characteristics 
The distribution of smokers among different age groups showed that the prevalence of 
smoking increases with age up to the age of 44 and decreases in later age groups. The mean age 
of the smokers was found significantly lower, i.e., 41 years as compared to non-smokers, which 
was 48 years. Similarly, the majority of the individuals in higher age groups, i.e., 55 years and 
older were nonsmokers. It is possible that the lower mean age and low proportion of smokers in 
higher age group can result in smokers dying early, either due to tobacco smoking alone or due 
to combination of other correlating factors linked to their smoking status. The relationship of age 
and smoking status among individuals with mental illness suggests that some kind of relationship 
exists between these two correlates. 
The demographic data from these individuals were analyzed, and it was found that both 
male and female are distributed pretty much equally in each category. There were 14 or 0.04% 
individuals who were classified as ‘Others’ in their gender. Data from these individuals were 
removed from the analysis to maintain confidentiality. Further data analysis was conducted after 
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removing these individuals from our dataset.  
The smoking status stratified by gender is consistent with the national average, but more 
pronounced in this study. This analysis showed that approximately 43% of females were smokers 
and 57% of males were smokers, as compared to the national data of 17% and 20% respectively 
for both females and males. The results clearly suggest a strong positive relationship of male 
gender with the smoking status of these individuals which is consistent with other similar 
studies. 
The majority of the individuals (49%) in this study were classified as ‘never married’. 
The analysis also showed that 26% of these individuals were married, and within the group 40% 
of the males were smokers and 30% of the females were smokers. These differences in smoking 
prevalence due to marital status highlight the importance of social factors in tobacco smoking. 
The relationship of education with smoking status of the individual didn’t differ much 
with the general population. Smoking prevalence was highest in individuals who went to High 
schools (grades 9~11) or finished high school. The proportion of smokers decreases in 
individuals with higher education with the lowest percentage of individuals with a graduate 
degree. These findings suggest that specific factors increase the likelihood of cigarette smoking, 
according to their level of education. 
The proportion of individuals admitted in mental health institutions in Ontario, showed 
that the majority of the individuals belong to Central Ontario. On the other hand, Northern 
Ontario represents the lowest number of individuals. Within the regions, smoking prevalence 
was highest in Northern Ontario as expected, due to large number of aboriginals living in that 
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area. The prevalence was lowest in the region of Toronto. These results are also consistent with 
the smoking prevalence in the general population. 
According to Statistics Canada, aboriginals constitute 3.26% of the Canadian population. 
Interestingly, the study also found that they constitute 2.97% of all the individuals admitted in 
the mental health institutions in Ontario. The study found that among aboriginal people, 72% of 
them were smokers, which was significantly higher than those who were non-aboriginals. This 
finding is consistent with the national data where smoking prevalence among these individuals 
was approximately 59%. This study reinforces the importance of addressing the issue of tobacco 
control especially in aboriginals. 
The majority of individuals were admitted due to specific psychiatric symptoms. The 
proportion of male smokers was higher in almost all the categories for admission as compared to 
non-smoking males. On the other hand, among female smokers, the proportion was lower in all 
the reasons for admission, as compared to non-smoking females, with the exception of problems 
with addiction/dependency, and involvement with the criminal justice system. The proportion of 
male and female smokers admitted with involvement in criminal justice system did not differ 
much (approximately 52 – 53% in each category). This suggests that the environmental and other 
social demographic variables that make an individual susceptible to smoke cigarette are affecting 
both the genders in the similar way. However, more research is needed to understand these 
factors that was beyond the scope of this study.  
Psychiatric Diagnosis 
The psychiatric diagnosis of the individuals in this study showed that Mood disorder was 
the most common diagnosis, followed by schizophrenia and substance-related disorders. The 
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study found a very strong correlation of substance-related disorder, schizophrenia and 
personality disorder with the smoking status of the individual, as determined by their primary (or 
most important) diagnosis. 
Earlier studies have shown that individuals with the diagnosis of schizophrenia smoke at 
nearly three times the rate of the general population. Some of the research has shown the rate 
increased to 86% in these individuals. However, the present study found the prevalence at three 
times the rate of the general population which is consistent with the overall prevalence in these 
individuals. The inpatient nature of the individuals and the conservative smoking status measure 
could have been the reason for this lower than expected prevalence in individuals with the 
diagnosis of schizophrenia. The nicotine dependence in these individuals may be very different 
than the individuals with a diagnosis other than schizophrenia, as earlier research has shown, but 
due to the lack of appropriate assessment measure for nicotine dependence in OMHRS, the study 
could not highlight this fact. 
The correlation of psychiatric diagnosis and smoking status differs much with respect to 
gender as well. The proportion of male smokers was considerably higher in individuals with the 
diagnosis of schizophrenia, mood disorders, anxiety disorder, somatoform disorders, sleep 
disorders, and personality disorders. This difference in proportion of smokers, due to their 
gender, can simply be a result of high smoking prevalence in overall smokers. Cochrane-Mantel 
Haenszel (CMH) statistics were used to find the difference in psychiatric diagnosis due to 
smoking status, after controlling the gender effect. The CMH statistics found significant 
difference in psychiatric diagnosis due to smoking status, after controlling the gender effect. The 
finding suggests that the prevalence of smoking among males is particularly high in substance-
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related disorders, personality disorders and schizophrenia. On the other hand, the highest 
prevalence of smoking among females was associated with personality disorder and substance- 
related disorders; unlike male smokers, the prevalence of smoking is lower in females with the 
diagnosis of schizophrenia as compared to the non-smoking females. Our initial literature review 
did not find a strong correlation of personality disorder and female gender. However, a study 
conducted in Finland (Tanskanen, 1997) found high smoking rates among females diagnosed 
with personality disorders. Since the data from our research can be comparable to census level 
data, it highlights the importance of this disorder in female smokers.   
Based on the correlation of psychiatric diagnosis and smoking status of the individual, the 
logistic regression model was used to calculate the odds ratio for being a smoker with respect to 
their psychiatric diagnosis, after controlling for gender and age. The study found that the odd of 
being a smoker is particularly high, i.e., 3.7 in individuals with substance-related disorder and 
1.2 in individuals with personality disorders. However, it will be very important to mention that 
these odds ratios are calculated for the individuals who are admitted in the mental health 
institutions in Ontario, rather than the general population. The odds ratio obtained for other 
diagnoses, such as mood disorders, anxiety disorders, etc., suggests that individuals with these 
diagnoses are less likely to be smokers, after controlling for age and gender. 
Social Support 
The results of our study suggested that smokers have less available social support and had 
fewer meaningful social relationships recently. Based on the available questions, in terms of 
indicators of anxiety, females had more anxiety-related issues as compared to males. However, 
within the group, male smokers had more problems with anxiety-related issues as compared to 
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male non-smokers. On the other hand, female smokers had fewer problems with anxiety-related 
issues as compared to female non-smokers. These results point out that some kind of social 
stigmatization exists due to smoking status of these individuals. 
In terms of psychiatric resource use, male individuals used more psychiatric resources 
than females, in terms of number of psychiatric admissions (both recent and lifetime). The 
number of admissions was higher among male smokers as compared to non-smoking males. On 
the other hand, the number of admissions was lower among female smokers as compared to non-
smoking females. 
In general, only 26% of the individuals exhibited any health complaints in the last 3 days. 
Proportionally, females exhibited more health complaints as compared to the males. However, 
the proportion of male smokers was high in exhibiting health complaints in the last 3 days. This 
is an interesting finding because, although smokers differ from non-smokers in many of the 
variables analyzed in this study, significant differences also exist due to gender. This needs to be 
explored further for better understanding of differences due to gender. 
Among those who were discharged within 30 days to 1 year, the proportion of male 
smokers was higher as compared to male non-smokers. In contrast to this, but similar to our 
earlier findings, the proportion of female smokers is less as compared to female non-smokers, in 
terms of time since last discharge within 30 days to 1 year.  
Among female smokers, the majority of them (48%) were admitted for the first time 
between the age of 15 ~ 24 years, followed by 43% at the age of 25 ~ 44 years of age. Similar 
trends exist for female non-smokers, but the proportion is higher. The proportion of smokers is 
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lower among those individuals in both genders who were first admitted after the age of 45 years. 
This suggests that either the non-smoking status of the individuals actually protected the 
individuals from their first psychiatric hospitalization or because they were not hospitalized, and 
as a result of that, they did not start to smoke. More research is needed in this area to find the 
true association between early of psychiatric hospitalization and the smoking status of the 
individual. 
Outcome Scales 
The outcome scales embedded in OMHRS shows that, proportionally, male smokers 
scored higher in almost all the scales as compared to female smokers. Although the majority of 
the scales being used in OMHRS are validated, more research is needed in this area to draw 
conclusions from these scales.  
In terms of cognitive performance, 67% of the smokers had intact cognition as opposed 
to 58% of the non-smokers. The overall trend shows that on cognitive performance scale 
smokers scored lower, i.e., they had better cognition, as compared to non-smokers. It could be 
either that the cognitively impaired persons forget to smoke cigarettes and quit early or it may be 
possible that the cigarette smoking may actually improve the cognition of the individuals. It is 
also worth mentioning that the mean age of the smokers is low, therefore, as a result of their 
lower age, they are cognitively better than the non-smokers.  
Alcohol/ Drug treatment/ Smoking cessation 
OMHRS uses only one question to identify smoking cessation as a focus of intervention. 
Since this question overlaps with alcohol and drug treatment as well, this study used a different 
An Epidemiological Analysis of smoking and smoking cessation 
 88
combination of variables in the analysis to answer the question, specifically about smokers. 
Overall, 73% of the individuals were not offered, did not receive, nor were scheduled to 
receive this intervention. Among smokers only, without any alcohol or drug problems, 89% of 
the individuals were not offered, had not received, nor were scheduled to receive this 
intervention. Gender stratified analysis also shows a similar trend. With respect to facilities, 10 
out of 64 facilities didn’t have this intervention at all.  
The odds ratio for getting the treatment suggested that the likelihood of getting this 
intervention is higher if a person has been diagnosed with a substance-use disorder. However, if 
a person has been diagnosed with a substance-use disorder in combination with being a smoker, 
the likelihood actually decreases. Similarly, the probability also decreases for individuals with a 
diagnosis of substance-use disorder in combination with alcohol use. On the other hand, if a 
person is diagnosed with a substance-use disorder in combination with both smoking and alcohol 
use, the odds of receiving the treatment increase slightly. 
The result of this analysis points to the fact that substance-use disorders are the main 
determinant for a person to receive an intervention focused at cessation of smoking/ alcohol or 
drug problems. However, the overlapping nature and the lack of standardized intervention make 
it difficult to understand the true nature of these interventions in various facilities. Earlier 
research has shown that smoking is not seen as a problem in individuals with mental illness. The 
findings from this study somehow validated this concept.  
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Study Limitations and Methodological Consideration 
The limitations of this study include: 
1) Crude measure of smoking status – OMHRS questionnaires have only one measure of 
smoking status of the individuals, while ignoring other important questions such as 
nicotine dependence, number of cigarette smoked, etc. 
2) Crude measure of provisional diagnosis – Since provisional diagnosis is mostly used 
for the current problem at the time of admission, and tends to ignore other problems 
which did not cause the problem that led to the admission. 
3) The data from this study was collected from various mental health facilities. These 
facilities have different regulations for smokers such as designated smoking areas, 
enclosed smoking spaces, and also how much control is exerted over the use of 
tobacco in their facilities. 
4) The dataset is representative of only the institutionalized individual (census level 
data) rather than the total population of individuals with mental illness within the 
province of Ontario. There is a possibility that these individuals may be slightly 
different from those who are not institutionalized.     
Policy Implications & Future Directions 
The Ontario Ministry of Health and Long-Term Care (MOHLTC) implemented the 
Smoke-Free Ontario Act on May 31, 2006. This act essentially put a complete ban on smoking in 
all enclosed public facilities, which also included psychiatric facilities. Despite the high smoking 
prevalence (three times the general population), differences in demographic characteristics and 
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differences in diagnosis, there are some provisions in the Act that allow smoking within these 
facilities, if certain conditions are met. This study not only validated earlier research that also 
found unusually high number of smokers admitted with mental illness, but also the use of census 
level data has highlighted the importance of taking appropriate action to reduce the smoking 
related consequences among these individuals. 
Even before the implementation of the Smoke-Free Ontario Act, some of the health 
facilities were actively working towards the reduction of the high smoking prevalence. These 
actions not only included enforcing a complete ban on smoking within the premises but they also 
offered programs or interventions to help these individuals quit smoking, based on DSM-IV 
guidelines. However, there are still many health units where more emphasis is given on the acute 
problem rather than paying attention to the smoking or providing interventions to help these 
individuals quit smoking. The reluctance to confront the smoking problem in individuals with 
mental illness has stemmed from beliefs such as exacerbation of symptoms during nicotine 
withdrawals, failure to succeed in quitting smoking, and the lack of skills to provide smoking 
treatment. From the policy perspective, addressing the issue of cigarette smoking in these 
individuals will not only reduce the health consequences associated with smoking, but rather it 
will decrease the likelihood of smoking initiation in these institutions. There are some unique 
advantages of smoking cessation programs among these individuals, for example, since the 
smoking prevalence is very high, the impact can be huge. The withdrawal effects can also be 
actively treated without any additional resources, because the individuals are institutionalized 
and already undergoing treatment for their psychiatric illness and so the facility can provide the 
perfect environment to help quit smoking. Mental health professionals have strong interviewing  
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techniques, and they are familiar with behavior change methods that are an essential part of the 
smoking cessation therapies. Having these skills increases the effectiveness of the smoking 
cessation programs and increases the odds of quitting. 
In the light of these findings, it is necessary to formulate better strategies for tobacco 
control, especially for these individuals. This issue hasn’t received attention it should have, due 
to concerns of the mental health professionals, families of the individuals, and policy makers. 
For most of them, smoking is a lesser evil as compared to the psychiatric problems and in this 
vein, many people believe that smoking is the only remaining pleasure in the lives of these 
mentally afflicted people and there is little desire to take away this last pleasure. On the other 
hand, a social stigma already exists for the individuals with mental illness. People tend to isolate 
these individuals and avoid them. With the growing attention towards tobacco control and 
increased awareness of the harmful effects of tobacco smoking in Canada, a social stigma exists 
for the smokers as well. People tend to stay away from these individuals and save themselves 
from second hand smoke. When an individual diagnosed with a mental illness tends to be a 
smoker, this stigmatization increases. In order to avoid this extreme stigmatization, effective 
tobacco control policies should be used to address the high prevalence of tobacco smoking 
among these individuals. 
Mental health units should not only enforce the Smoke Free Ontario Act, but the ministry 
should also support the facilities in developing a standardized intervention to help these 
individuals quit smoking. While the spontaneous cessation rate for people with mental illness 
and addiction was found extremely low (Ziedonis, 1997), there is also some evidence to indicate 
that many individuals with mental illness and addictions want to reduce the amount they smoke, 
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or stop smoking altogether (Addington et al., 1997; Carosella et al., 1999; Forchuk et al., 2002; 
Goldberg et al., 1996). The appropriate measures, in terms of increasing the availability and 
standardized delivery of the smoking cessation intervention, have huge potential of reducing the 
high prevalence of smoking in these individuals. 
Recommendations for InterRAI group 
Ontario Mental Health Reporting System is a unique tool developed mainly to support 
inpatient mental health services planning in mental health institutions. It uses minimum data that 
contains variables that can be used to screen various health problems. The outcomes scale and 
quality indicators have huge potential for research. Specifically, for smoking-related problems, 
the quality indicator “Prevalence of smoking/ tobacco addiction without an offer of therapy” 
should be used as a measure to increase the tobacco control strategies in the respective facilities. 
Despite the limitations, in terms of adding more data items in OMHRS, the addition of  the 
number of cigarettes smoked and nicotine-dependence measures could provide valuable 
information  with the goal of  providing appropriate treatment for these individuals. However, 
OMHRS is especially developed for the province of Ontario, and since this study has found an 
unusually high prevalence of cigarette smoking in these groups, the addition of smoking-related 
details can certainly help the provincial government take strong measures in this particular area. 
Recommendations for future research 
Future work should focus on more data on the smoking status of the individual, such as 
the number of cigarettes smoked and information on nicotine dependence, etc. The measure of 
smoking should be improved to identify former smokers from current smokers. The details of 
smoking cessation intervention and the regulations to control cigarette smoking in the facilities 
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should be studied. Longitudinal data analysis should be carried out to assess the cause and effect 
phenomena in many of the study variables.  
Conclusion 
Tobacco smoking is highly prevalent among individuals with mental illness in Ontario. 
The prevalence of smoking is particularly high in individuals with mood disorders, 
schizophrenia, and personality disorders. Males are more prone to smoking and smokers are 
more likely to have less social support as compared to non-smokers. 
Smokers are less likely to receive an intervention focused on alcohol/ drug/ and tobacco 
cessation. Smokers with a diagnosis of substance-use disorders and alcohol use are 5 times more 
likely to receive this intervention, as compared to those smokers who do not have any of these 
problems. Smokers scoring high on positive symptoms scale are less likely to receive the 
cessation. 
Concentrated efforts are needed to control cigarette smoking in this population. The 
availability of smoking cessation intervention is needed in many of the facilities. 
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 New Patient 
Violence Revolving Door  
Self-Harm Discharge Resources 
 Abuse by Others Addictive Behaviors 
Criminal Activity Nutrition  
Self-Care Dehydration 
 Social Function Polydipsia 
Interpersonal Conflict Skin and Foot Conditions 
 
Vocational Rehabilitation Oral Health 
 Support System Pain 
Economic Status Bladder/ Bowel Functioning 
 
Adherence Cognition 
Psychotropic Drug Review Communication Disorders  
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Cognitive Performance Scale Substance Addictions Screen 
Depression Rating Scale IADL Summary Scale 
Negative Rating Scale Health Status Index 
Anxiety Scale ADL Hierarchy Scale 
Aggressive Behavior Scale ADL Short Form Scale 
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Behavioral Emotional Patterns 
• Remission rate of symptoms of depression 
• Incidence of Symptoms of Depression 
• Remission rate of aggressive behavior disturbance 
• Incidence of aggressive behavior disturbance 
• Remission rate of disruptive behavior disturbance 
• Incidence of disruptive behavior disturbance 
Nutrition/ Eating 
• Incidence of Weight Loss 
• Incidence of Weight Gain 
• Prevalence of Dehydration 
Cognitive Patterns 
• Remission of Hallucinations 
• Improvement of Cognitive 
Impairment 
• Incidence of Cognitive … 
Physical Functioning 
• Improvement of ADL functioning 
• Incidence of ADL functioning 
• Improvement in Finance Management IADL 
• Incidence in Finance Management IADL 
• Improvement in Medication Management IADL 
• Incidence in Medication Management IADL 
Restraint Use 
• Prevalence of Chemical 
Restraint Use 
• Prevalence of Physical 
Restraint Use 













• Prevalence of Extra-pyramidal Symptoms 
• Prevalence of Rehospitalization  ? 
• Prevalence of Unauthorized Leaves of Absence 
• Prevalence of Self-Injury (Non-suicidal) 
• Prevalence of Pain without Analgesic Use or Pain Management 
• Prevalence of Smoking/ Tobacco Addiction without an Offer of Therapy 
• Prevalence of Signs of Substance Abuse without Therapy 
• Prevalence of Psychotropic Medication Underuse 
 
 
 
 
 
